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ABSTRACT
Physiology of the pulmonary pacemaker: a new regulator of
lung growth
NC Featherstone
Background: Pulmonary hypoplasia and pulmonary hypertension
account for the high mortality in Congenital Diaphragmatic Hernia (CDH).
Factors involved in determining lung growth are thus of interest:
spontaneous contractility of embryonic airway smooth muscle (ASM)is
one such mechanical factor.
Aim: To examine the physiological mechanisms underpinning
spontaneous airway contractility (‘airway peristalsis’) in normal and
hypoplastic lung andrelate these to pulmonary development.
Methods:Sprague-Dawley rats were fed 100mg nitrofen on Day 9.5 of
pregnancy to induce lung hypoplasia in offspring (controls had vehicle
alone). Normal and hypoplastic lung primordia were cultured from Day
13.5 of gestation at 37°C in 5% CO, and loaded at 54 or 78 h with calcium
(Ca’*)-sensitive indicators: Fluo-4 for confocal imaging and Indo-1 or
Fura-2 for photometric measurements of Ca”’;.
Results: Peristalsis of the embryonic airways was driven by spontaneous,
regenerative, temperature-sensitive Ca", waves. These Ca’*; waves
propagated between individual ASM cells coupled by gap junctions, were
likely to be action potential-mediated, and were dependent on not only
extracellular Ca** (Ca’*,) entry via L-type voltage-gated channels but also
intracellular stores. Hypoplastic lung also featured spontaneous
propagating ASM Ca”’; transients, but with reduced frequency, increased
amplitude, and significantly prolonged plateau duration, relative to control
lung.
Conclusions: Spontaneous prenatal Ca‘; waves underpin airway
peristalsis in embryonic rat lung. If as recent data suggest, airway
peristalsis regulates prenatal lung growth, then we can assert intercellular
Ca’; oscillations in turn regulate antenatal lung development. Early ASM
dysfunction in lung hypoplasia is apparent as specific anomalies of Ca”*j
transients and may suggest key problemsin the ASM ion channels / action
potential generation. These changes accompany early hypoplasia and
precede visceral herniation; they may underlie, in part, later post-CDH
ASM abnormalities (airway hyperactivity).
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Chapter 1
INTRODUCTION
1.1 Congenital diaphragmatic hernia
1.1.1 Definition and Classification
Congenital diaphragmatic hernia (CDH) comprises the posterolateral
Bochdalek diaphragmatic malformation (Figure 1.1), intra-thoracic
herniation of abdominal viscera and pulmonary hypoplasia (Bochdalek
1848). The malformationis left sided in 78% of cases, right sided in 21%
and bilateral in 1% (Clark et al. 1998; Neville et al. 2003).
CDH differs from the rarer Morgagni hernia in which the diaphragmatic
defect lies anteriorly in a retrosternal position (Baran ef al. 1967). This
thesis only considers the commonest form, the Bochdalek defect due to its
more severe prognosis; it continues to challenge neonatologists and
paediatric surgeons despite advancesin care.
1.1.2 Epidemiology
Determining the true incidence of CDH is problematic. A number of
fetuses with CDH will be lost antenatally either spontaneously or though
termination. Some CDH newbornswill die before transfer to the surgical
centre for definitive repair. CDH detected outside the perinatal period may
not be included in epidemiological studies resulting in errors of estimation.
Lastly, population-based studies may be affected by ascertainment bias
(Beresford et al. 2000; Stege et al. 2003; Ontario Congenital Anomalies
Study Group 2004; Colvin et al. 2005; Dillon et al. 2000). Different
countries and regionsdiffer in their abilities to ascertain data and create
 
Figure 1.1. Chest and abdominal radiograph showing a newborn with
left congenital diaphragmatic hernia (CDH). Loops of bowel can be
seen the left hemithorax. The heart is displaced to the right. Vertebral
defects can also be seen. Radiograph courtesy of Dr David Pilling
(Consultant Radiologist at The Royal Liverpool Children’s Hospital,
Alder Hey).
registries of antenatally and postnatally detected cases of CDH (Garne et
al. 2005; Rankin et al. 2005). Given these caveats, it has been estimated
that CDH has an incidence of approximately 1 in 2500 births such that a
new case is born in the United Kingdom every 24-36 hours (Smith ef ai.
2002).
1.1.3 Aetiology
Although the aetiology is largely unknown, CDH has been reported in
conjunction with the maternal administration of thalidomide and
phenometrazine (Hobolth 1962; Powell et al. 1962). A small number of
cases exhibiting familial inheritance exist within the literature (Tibboel et
al. 1996; Kufeji et al. 1999).
CDHoccursas an isolated defect in the majority of cases; however, it may
co-exist with other major anomalies (cardiac and neural tube being
particularly prominent) in one quarter to one third of cases (Benjaminefal.
1988; Sweed ef al. 1993). However, in approximately 10%, it forms a
component of a syndromic genopathy (Witters ef al. 2001). Genetic
syndromes include Fryn’s, Denys-Drash, Goldenhar’s, Brachmann-de-
Lange, Beckwith-Wiedemann and Pallister-Killian (Dillon ef al. 2000;
Borys et al. 2004; Ahn et al. 2005; Slavotinek 2007). Associated anomalies
increase mortality markedly; 93% of newborns with CDH and major
anomalies have been reported to die, either antenatally or early within the
postnatal period (Beresford et al. 2000).
1.1.4 Pathology
There is a clinical spectrum of disease in CDH ranging from newbornsthat
do well with conventional mechanical ventilation, to the sickest requiring
advancedstabilization strategies for the opportunity to survive.
Hypoplastic lungs are morphologically abnormal; CDH results in a
reduction in lung weight, volume, airway generation and alveolar number.
There is also abnormal development of bronchiolar cartilage, abnormal
muscularisation of the pulmonary arteriolar wall and decreased cross-
sectional area of the pulmonary vascular bed (Nakamura ef al. 1991;
Kitagawaet al. 1971; Adzick et al. 1985). In addition, the lungs may be
stiff, non-compliant and atelectatic as a result of surfactant deficiency
(Moya et al. 1995; Alfanso et al. 1996; Valls-i-Soler et al. 1996).
Pulmonary vascular adaptation to postnatal life has been demonstrated to
be delayed in CDH newborns; normally, pulmonary artery pressures fall
rapidly at birth, however in CDH,it may take weeks to normalize (Haugen
et al. 1991). The resulting elevation in pulmonary vascular resistance
producesright to left shunting and hypoxaemia. Hypoxiaresults from these
anatomical, biochemical and physiological abnormalities of the CDH lung.
1.1.5 Animal Models for Congenital Diaphragmatic Hernia
Four types of animal models for CDH can be identified 1) naturally
occurring 2) surgically created 3) teratogen-induced and 4) transgenic.
They provide investigators with tools with which to study pulmonary
development in CDH; they may provide insights into the pathogenesis of
this lethal condition, which may then betranslated to the clinical setting.
However, certain caveats must be borne in mind when using these
experimental models.
1.1.5.1 Naturally occurring CDH
CDH wasreported to occur naturally in a herd of pigs that was bred to
produce anorectal malformations (Ohkawa ef al. 1992). Symptoms
occurred 1 to 4 months postnatally. Despite herniated organs being found
within the thoracic cavity, the lungs do not exhibit the hypoplasia that is
characteristic ofhuman CDH.
1.1.5.2 Surgically created CDH
Surgically created models of CDH are based on the traditional thesis that
lung hypoplasia results from compression by the herniated abdominal
viscera. The first model was described in 1967 and involved creating a
diaphragmatic hernia in third trimester fetal lambs (De Lorimier ef al.
1967). Subsequently, many investigators have used a variety of techniques
based upon this principle in a variety of species (mainly ovine) to
investigate the pathophysiology of CDH (Haller et al. 1976; Harrison etal.
1980; Adzick et al. 1985; Fauza et al. 1994; Wu et al. 2002; Roubliova et
al. 2004). Usually, time-dated ewes are operated upon at mid-gestation to
expose the fetus; a diaphragmatic defect is created via a posterolateral
thoracotomy. Stomach, omentum and smallintestine are then placed in the
chest. The thoracotomy is closed and the pregnancy maintained with
tocolytics.
This model produces several similarities to human CDH; the lungs exhibit
hypoplasia, reduced number of airway branches and alveoli, diminished
pulmonary vasculature and increased muscularisation of the pulmonary
arteries (Lipsett ef al. 2000; Ting ef al. 1998). Prenatal ‘repair’ of the
surgically created defect resulted in reversal of the pulmonary hypoplasia
(Harrison et al. 1980). As a consequence, paediatric surgeons investigated
in-utero repair of congenital diaphragmatic defects; a prospective
randomised trial showed no benefit in humans compared with standard
postnatal management(Harrisonet al. 1997).
New trials of temporary tracheal occlusion commenced following the
finding that congenital laryngeal obstruction resulted in hyperplastic lungs
(Silver et al. 1988). Initially, the trachea was occluded using clips that
required surgical removal prior to birth, and later, via an inflatable
detachable balloon (Skarsgard et al. 1996). However, temporary balloon
occlusion did not prevent the development of lung pathology associated
with pulmonary hypoplasia (Harrison et al. 2003), nor did it improve
survival or morbidity rates (Heeremaet al. 2003). Despite this, human fetal
programmes in North America and Europe continue to investigate fetal
endoscopic techniques in selected high-risk fetuses (Keller et al. 2004;
Deprestet al. 2005; Saura et al. 2007).
There are a numberof problemsassociated with surgically created models
of CDH. Ovine fetuses undergo antenatal surgery exposing them to
pharmaceutical agents / mechanical ventilation. The fetuses are otherwise
normal and lack the associated defects (e.g. cardiac or chromosomal)
which are often seen in human CDH and may contribute to its high
mortality. Large animal studies are inherently expensive due to the costs of
maintaining the stock, operative costs and drugs. Economic costing and a
high rate of fetal loss following antenatal surgery limit the size of
experimental groups. The timing of surgery is also pertinent in that
according to the compression theory herniated viscera should inhibit
growth from the early pseudoglandular stage. However, the ovine surgical
model of CDH is usually created during the late pseudoglandular or
canalicular stages of lung development (de Lorimier et al. 1967; Adzick et
al. 1985). As a result, the resulting pulmonary defects may be dissimilar to
human CDH.Lastly, the surgically created model is not able to provide
any insights into the pathophysiology of CDHat an embryoniclevel.
1.1.5.3 Teratogen-induced CDH
A numberof chemicals have been described that induce CDH in rodents
(Taleporoset al. 1978; Iritani 1984). Vitamin A deprivation in rodents also
results in CDH in the offspring (Wilson et al. 1953). Perhaps the most
popular teratogen used to induce CDH is nitrofen (2,4-dichloro-4’-
nitrodiphenylether). It is administered to pregnantrats (single gavage feed)
on a specific point in gestation to induce CDH in a proportion of the
offspring (Kluth et al. 1990; Kluth et al. 1993; Kluth et al. 1996a; Kluth et
al. 1996b). It provides the singular opportunity to study CDH at an
embryological level (prior to closure of the diaphragm).
However it is unclear how nitrofen actually induces CDH (e.g. it is
unknown whether nitrofen itself or one of its metabolites is the active
teratogen) (Noble ef al. 2007). Nitrofen has similarities to thyroid hormone
and it has been suggested that it may work through disruption of thyroid
metabolism (Figure 1.2) (Tovar et al. 1997). However, nitrofen does not
appear to alter thyroid hormonesignalling or receptor function (Noble ef
al. 2007). Neither does it seem to involve the oxidative effects of nitrofen
(Noble et al. 2007). Rather, it appears to inhibit the rate-limiting enzymes
that control retinoic acid synthesis (Greer et al. 2003; Noble et al. 2007).
Nitrofen-exposed pups without CDH also exhibit pulmonary hypoplasia
comparedto controls (Kluth et al. 1990; Kluth et al. 1993; Brandsmaetal.
1995; Losty et al. 1996b). As a consequence, there are some concernsthat
the pulmonary abnormalities may arise as a direct effect of nitrofen itself.
Also, there appears to be no correlation between nitrofen exposure and
CDH in humans(Boset al. 1994). Nor does nitrofen necessarily produce
CDH in non-Sprague-Dawley rat strains, raising questions regarding its
species-dependent method of action (Kang et al. 1986). Despite these
concerns, nitrofen remains popular as it is cheap, simple to administer and
AT
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Figure 1.2. Schematic diagram depicting the molecular structure of
A) nitrofen (2,4-dichloro-4’-nitrodiphenylether) and B) thyroxine.
Nitrofen exhibits stereochemical structural similarity to thyroid
hormone and its teratogenic effects have been speculated to be a
consequenceofaltered thyroid hormone metabolism.
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permits investigation of pulmonary development during CDH
embryogenesis.
1.1.5.4 Transgenic models of CDH
Morerecently, the use of rodent genetic technology has provided new tools
with which to investigate diaphragm development and CDH. Several
mutant phenotypes have been described in which CDHfeatures. However,
they often frequently exhibit other malformationsthat result in them being
phenotypically different from human CDH. Deletion of both murine
retinoic acid receptors (RARs) results in a high incidence of cranial,
vertebral, limb, cardiac, foregut and pulmonary malformations but only
yields a low frequency of CDH (Lohneset al. 1994; Mendelsohn et al.
1994). Mice with Hlx gene mutations (a homeoboxtranscription factor
gene) have CDH, but, have large lungs and small liver and intestine
(Hentsch et al. 1996). Homozygousinactivation of WT-1 (Wilms’ Tumour
suppressor gene) results in CDH, but the mice are severely deformed and
have severe urogenital anomalies (Kreidberg et al. 1993). Mice
homozygous for Slit3 (slit homolog 3 [drosophila]) deficiency exhibit
CDH,but the hernia is located within the central tendon, rather than the
posterolateral diaphragm (Liu et al. 2003). In these mice, the hernias
contain the liver and gallbladder, and a large proportion of mice exhibit
urogenital anomalies (renal / ureteral agenesis). Murine COUP-TFII-null
mutants (COUP-TFII is a member of nuclear receptor superfamily that
1]
plays a critical role during mouse development) exhibit Bochdalek-type
CDH and the stomach andliver protrude into the thoracic cavity (You et
al. 2005).
These models may in time, permit investigation of the pathophysiology of
CDH. Like the nitrofen model of CDH, they would allow study at the
embryological stage. However, at present many phenotypic differences
exist between the models and human CDH which currently limits their use
on a widescale.
1.1.6 Pathogenesis
The causation of the hypoplastic lung in CDH remains unknown.Several
explanations have been proposed; these have been derived from clinical
observation and studies of developmental biology utilising animal models.
Herniated abdominal viscera may compress the developing lung and
prevent normal development. Evidence supporting this arises from the
sheep model of CDH, in which a surgically created defect and manual
herniation of the viscera result in lung hypoplasia (De Lorimier ef ai.
1967). Reduction of the herniated material and repair of the defect whilst in
utero produces lung enlargement (Harrison ef al. 1980a; Harrison efal.
1980b).
Alternatively, an abnormality of pulmonary development may already exist
prior to closure of the diaphragm at 8 weeks of age in the human fetus.
Various teratogens that induce CDH havebeenutilised in animal models to
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test these hypotheses (Taleporos ef al. 1978; Iritani 1984; Kang ef al.
1986). Nitrofen (2,4-dichloro-4’-nitro diphenyl ether) murine (mouse or
rat) models of CDH are one of the most commonly used (see section
1.1.5.3). At day 13.5 of gestation, 24 hours after lung primordia develop
from the foregut, the normal lung and twothirds of nitrofen-exposed lungs
have > 6 buds, in contrast, one third of nitrofen exposed lungs have less
than six buds. When followed longitudinally utilising organ culture
techniques, the nitrofen lungs show reduced bud counts, area and perimetry
(Jesudason et al. 2000). These findings suggest branching morphogenesis
is disrupted prior to diaphragmatic closure.
However, lung hypoplasia may occur through a combination of these
hypotheses. Keijzer et al. suggested that there may be a ‘dual hit’ upon the
developing lung. He postulated that: 1) the lungs were intrinsically
abnormal prior to closure of the diaphragm, and; 2) growth was further
impaired through compression by herniated viscera (Ketjzer et al. 2000).
Diaphragmatic defects mayalso result in fluid loss from the lungs through
dysfunction of the diaphragm. Studies have shown drainage of lung fluid at
regular intervals during pregnancy results in lung hypoplasia, whereas
perfluorocarboninstillation and fetal tracheal occlusion producesfetal lung
enlargement (Fauza et al. 2001; Alcorn et al. 1977; Moessingeret al. 1990;
DiFiore et al. 1994; Adzick et al. 1985).
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1.1.7 Management
The first successful neonatal CDH repair was performed in 1946 by Robert
Gross (Gross 1946). During the last half-century, several stabilisation
techniques (extracorporeal membrane oxygenation (ECMO), high
frequency oscillatory ventilation (HFOV), nitric oxide (NO) inhalation,
and permissive hypercapnia) and advancesin prenatal therapy have been
introduced. Novel therapies such as liquid ventilation (LV), surfactant
therapy and steroids have also been investigated (Hirschl et al. 2003; Van
Meurs 2004; Lally et al. 2006; Logan et al. 2007).
Despite these developments, mortality has changedlittle when the ‘hidden
mortality’ (antenatal and early postnatal deaths prior to transfer to the
definitive paediatric surgery centre) is considered; mortality remains as
high as 60% (Stege et al. 2003; The Ontario Congenital Anomalies Study
Group 2004; Colvin et al. 2005; Dillon et al. 2000). The majority of these
deaths result from the associated pulmonary hypoplasia and accompanying
pulmonary hypertension (Skari et al. 2000).
Approximately 50 — 60% of cases are detected antenatally via routine
obstetric ultrasound scanning (often prior to 25 weeks gestation)
(Thilaganathan 2002; Garne et al. 2002; Dillon et al. 2000). In the UK,
most antenatally detected cases of CDH are detected upon the 20-week
routine anomaly scan. It is possible to diagnose CDHas early as the wi"
weekof gestation, but a European multi-centre study has shown the mean
age at diagnosis is 24.2 weeks (Garne ef al. 2005). Visualisation of the
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stomach, liver or intestines within the thoracic cavity confirms the
diagnosis. Mediastinal shift away from the side of the defect may also be
noted. Antenatally detected cases should ideally be referred to a specialist
centre such that a miulti-disciplinary medical team, consisting of
obstetrician, neonatologist and paediatric surgeon may then counsel the
parents and plan delivery and managementoptions.
However, predicting the outcome and survival for antenatally detected
CDHcasesisdifficult; many parameters have been proposed and evaluated
over time. For example, polyhydramnios (Adzick et al. 1989), presence of
stomach herniation (Burge ef al. 1989) and abdominal circumference at the
level of the umbilical cord (Teixeira et al. 1997) have all been associated
with poor outcomein studies (Metkuset al. 1996); but none are absolutely
predictive of postnatal death.
Lung head ratio (LHR) was suggested as a marker of prognosis by
Harrison’s group in San Francisco (Lipshutz et al. 1997). It is the ratio of
the area of the lung contralateral to the hernial defect to the fetal head
circumference. Measured via ultrasonography at the level of the atria (so-
called ‘four-chamberview ofthe heart’) it minimizes discrepancy owing to
gestational age. LHR levels have been subdivided into categories: <1, 1-
1.4, and >1.4. They have been reported to show goodapplicability in the
prediction of fetal outcome within retrospective and prospective study
populations, with 100% survival if LHR >1.4 and 100% mortality if LHR
<1 (Laudy et al. 2003; Keller et al. 2003; Lipshutz et al. 1997); the
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outcomeis not so clear for those with a mid-range LHR. Morerecently, the
relationship between LHR andgestational age has been investigated; it has
been suggested that LHR predicts postnatal survival in fetuses at 24-34
weeks of gestation, but less reliably at 20-24 weeks (Yang et al. 2007).
However, others have reported that a LHR of <1 does not predict postnatal
survival and as such, should not be used as a factor for choosing fetal
intervention (Arkovitz et al. 2007). Indeed, a recent meta-analysis of the
current prognostic use of LHR in fetal surgery shows lack of a sufficient
evidence base and is impaired by overlapping and methodologically
diverse reporting (Ba’ath et al. 2007). There is a paucity of information
available on normal LHR values and inter-observer and inter-institution
variations in its measurement may exist (Ba’ath ef al. 2007). Further
evaluation of LHRis therefore required.
Both prospective and retrospective studies have determined that liver
herniation (‘liver up cases’) and early diagnosis (less than 25 weeks
gestation) markedly reduce survival (Adzick et al. 1985; Albanese ef al.
1998). It may be that large symptomatic hernias are detected easily on
ultrasonographic scanning resulting in lead-timebias.
Antenatal magnetic resonance imaging (MRI) holds promise in CDH
assessment; it has been shown to yield information additional to that
gained by ultrasonography in fetuses with thoracic abnormalities (Levine et
al. 2003; Hubbard et al. 1999; Neff et al. 2007; Cannie et al. 2008).
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If CDHis not diagnosed antenatally, the majority will present with signs of
respiratory distress within the first few minutes of life. A small subset of
patients may presentat a later date, often with insidiousclinical signs that
may notberelated to the herniaitself (‘late presentation CDH’).
A team of paediatric surgeons, neonatologists and anaesthetists should care
for the baby once born. Elective intubation should be performed (avoiding
barotrauma or volutrauma to the hypoplastic lung) and a nasogastric tube
passed to prevent dilatation of the bowel and resulting compromise of
respiratory function.
Radiographic investigations confirm the diagnosis: chest radiographs may
show loops of bowel within the thoracic cavity, mediastinal shift or
occasionally abnormalposition of a naso-gastric tube indicating displaced
viscera. Rarely, an upper gastrointestinal contrast study may be required to
provide further information. Alternative pathologies, such as
cystadenomatous lung lesions, can normally be excluded with the aid of
ultrasonography.
Historically, repair was undertaken as an emergency, but over time,
practice has gradually shifted to a policy of stabilization using a variety of
ventilatory strategies before operation. It was recognised early surgery did
not necessarily result in an improved outcome. Randomized prospective
studies and retrospective studies have been performed to determine optimal
timing of surgery for infants with congenital diaphragmatic hernia. Many
have demonstrated no benefit in undertaking immediate surgery (Nioetal.
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1994; Shanbhogue ef al. 1990; Langer et al. 1988). The Cochrane
collaboration concluded similar findings, but stated a large, multicenter
randomized trial would be needed to fully answer this question (Moyer et
al. 2002). Newborns undergo physiological remodelling following birth to
prepare for postnatal life. Permitting these adaptations to take place, whilst
in an intensive care setting and prior to surgery, may result in improved
outcomes.
It is now recognised that is important to use ventilatory strategies that
exploit low tidal volumes and pressures to minimise volutrauma and
barotrauma (‘gentilation’). High ventilation pressures, high-end expiratory
volumesand repeated opening andclosing of alveoli during the respiratory
cycle have been shown to cause lung injury (Wungef al. 1985; Boloker et
al. 2002; Downardet al. 2003; Smith et al. 2002).
Extracorporeal membrane oxygenation (ECMO)is a heart-lung bypass
technique utilised for severe but potentially reversible respiratory failure
and cardiac failure in children and adults. It was first utilised in a neonate
in 1975 (Bartlett 1976). It may be employed for pre-operative stabilisation,
or post-operative rescue in CDH newborns. Surgery may even be
performed whilst on ECMO,although care must be taken with regards to
anticoagulation. Early retrospective studies from single institutions, using
historical controls for comparative data, suggested ECMO may improve
survival (Weberet al. 1987; D’Agostino et al. 1995; Atkinson ef al. 1991).
Likewise, the Congenital Diaphragmatic Hernia Study Group reportedthat
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ECMOsignificantly improved survival rates for newborns with CDH with
a predicted mortality of > 80% (The Congenital Diaphragmatic Hernia
Study Group 1999). Conventional mechanical ventilation (CMV) and
ECMOwere compared to CMV andhigh frequencyoscillatory ventilation
(HFOV), as rescue therapies, in two large tertiary care paediatric centres
(‘A tale of two cities’); CMV with ECMOresulted in an overall survival
similar to CMV with HFOV (Wilson et al. 1997; Azarow et al. 1997). The
Cochrane Group concluded ECMOprovided short-term benefits for the
CDH newborn; however, the overall effect was not clear (Elbourne ef al.
2002). In comparison, it led to significantly improved survival in mature
infants with potentially reversible respiratory failure, who did NOT have
CDH (Elbourne ef al. 2002). Previously, the UK Collaborative ECMO
Trial Group had reported that ECMO was beneficial and should be actively
considered for neonates with severe but potentially reversible respiratory
failure (UK Collaborative ECMOTrial Group 1996).
High frequency oscillatory ventilation (HFOV) operates at low airway
pressures, tidal volumes and end-expiratory volumes; consequently, it
avoids barotrauma and volutrauma. Anecdotal reports from centres suggest
CDHpatients show benefit with this technique, compared to conventional
mechanical ventilation (Azarow ef al. 1997; Karl et al. 1983; Arnold
2000). One suchreport from Italy stated that HFOV had improvedsurvival
from 67% using CMV to 94% (Cacciari et al. 2001). However, as yet, no
randomised controlled evidence exists to support its widespread use.
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Nitric oxide is an endogenous,free radical that has vasodilatory effects via
cyclic GMP on the pulmonary vasculature in both animal models and
humans.Identified as endothelial derived relaxing factor (EDRF) in 1987
(Palmer et al. 1987), it has a short half-life and is rapidly oxygenated to
nitrates and nitrites. Inhaled nitric oxide (INO) was introduced as an
alternative to systemic vasodilators such as tolazoline and prostacyclin, for
the treatment of persistent pulmonary hypertension (and thereby avoid their
side effect profile, including marked systemic hypotension) (Stevensef al.
1980; Bloss et al. 1980). Theoretically, iNO is beneficial for treating
pulmonary hypertension in CDHas itis directed to well-ventilated areas of
lung, resulting in targeted vascular relaxation and decreased pulmonary
hypertension. Only a few studies have investigated the use of iNO as a
selective vasodilator in CDH. The Neonatal Inhaled Nitric Oxide Study
Group (NINOS) reported that although NO provided short-term
improvements in oxygenation, it did not reduce the proportion of patients
requiring ECMO or mortality rates (The Neonatal Inhaled Nitric Oxide
Study Group (NINOS) 1997). Similarly, a Cochrane systematic review
concluded that iNO did not improve the outcome of newborns with CDH
(Fineret al. 2000).
Permissive hypercapnia was developed to avoid lung damage through
avoidance of high ventilatory pressures and high tidal volumes. The
technique permits neonates to breathe spontaneously at a high rate
achieving a normal minute volume. Low airway pressures prevent
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compromise of venous return and cardiac output. An elevated P,CO> is
accepted within regulated limits. Hypercapnia may be beneficial as it
maintains cerebral blood flow by avoiding hypocapnic-mediated
vasoconstriction, and aids CO) elimination from the lungs as a higher
concentration ofCOis exhaled per breath. Elevated levels ofCOproduce
a right shift in the oxygen dissociation curve, decreasing affinity of
haemoglobin for oxygen, resulting in increased release of O, in the
peripheries. Conversely, this may also reduce oxygen uptake within the
alveoli. Excessive hypercapnia should be avoided to prevent severe
metabolic acidosis.
In 1985, Wung ef al. from New York, reported impressive survival rates
utilising this novel technique (Wungef al. 1985). The majority of infants
(84.4%) survived to discharge and showedlittle in the way of pulmonary
morbidity. Preductal PaO, is maintained in the range 50 — 70mmHg and
permits PaCO, to rise to 60mmHg, whilst maintaining spontaneous
respiration on the ventilator. Hyperinflation and alkalisation were avoided
to prevent lung barotrauma and exacerbation of pulmonary hypertension
(Wungef al. 1995; Boloker et al. 2002). Similarly, Wilson’s Boston group
reported survival rates of 93% using this approach (Downardetal. 2003).
The technique for open repair has changedlittle over time; classically, the
defect is approached via a thoracic or abdominal (subcostal) incision.
Herniated viscera are reduced carefully into the abdomen,the defect being
closed either primarily (Figure 1.3) or using a patch. Prosthetic material
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Figure 1.3. Intra-operative repair of congenital diaphragmatic hernia
(CDH). In the upper image, the defect has been defined. The anterior
and posterior rims are evident. In the lower image, the defect is being
closed with interrupted sutures. Images courtesy of Professor Paul
Losty, The Royal Liverpool Children’s Hospital, Alder Hey.
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includes polytetrafluoroethylene (PTFE; Gore-Tex [W.L. Gore and
Associates, Flagstaff, AZ]), SILASTIC® (Dow Corning, Midland, MI),
Dacron, and polypropylene. Muscle flaps based on the latissimus dorsi
(Bianchi et al. 1983; Sydorak et al. 2003), internal oblique and
transversalis (Scaife ef al. 2003) have been used to patch the defect and
recurrences. These autologous techniques may have benefit in the long-
term, as up to 40% of hernias recur when repaired with prosthetic patches,
necessitating re-repair (Moss ef al. 2001). Others have reported the use of
SILASTIC® mesh to enlarge the abdominal cavity, preventing an increase
in intra-abdominal pressure when herniated viscera are reduced
(Michalevicz et al. 1989).
A few groups have utilised the endosurgical approach in selected cases of
CDH with favourable results (Shah et al. 2002; Taskin ef al. 2002).
Advances in neonatal endosurgery, including smaller instruments and
optics have facilitated such operations. Insufflation pressures need to be
kept low to prevent respiratory embarrassment and reduced venousreturn.
Studies have been published stating laparoscopy should not be considered
for newborn with CDHas the failure rate is high and there are problems
relating to the pneumoperitoneum and rising PCO, levels (Arca ef al.
2003). However, the thoracoscopic approach maybebeneficial as it allows
spontaneous reduction of the herniated viscera into the abdomen and
permits diaphragmatic suture with minimal visceral handling
(Schaarschmidt et al. 2005).
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Fetal surgery was introduced in the 1970’s as conventional therapies
available at that time didlittle to improve the outcome for CDH newborns
(Lipshutz et al. 1997). Early repair of CDH in-utero in an experimental
lamb model revealed improved lung growth (Harrison ef al. 1980a;
Harrison et al. 1980b). Fetal surgery has been limited to fetuses with a
prediction of poor outcome. However, as discussed above,selecting ‘high-
risk’ fetuses for prenatal surgery requires accurate prognostic scoring. At
present, there is a lack of evidence base to support the use of LHR in
selecting fetuses for prenatal surgery (Ba’ath et al. 2007). Initially, open
fetal repair was performed, but abandoned due to high mortality, mainly
through premature labour, but also due to obstructed venous return, when
attempts were made to reduce the herniated liver (Harrison et al. 1993).
The observation that congenital laryngeal obstruction in infants resulted in
hyperplastic lungs, led to attempts at tracheal occlusion (Silveret al. 1988).
This technique became known as PLUG (‘Plug the LUng until it Grows’)
(Hedrick et al. 1994; Bealer et al. 1995; Skarsgard et al. 1996; VanderWall
et al. 1996; Beierle et al. 1996). The trachea was occluded at 24 — 26
weeks gestation using clips placed via the fetal endoscopic route (Fetendo
Clip); the technique was modified later to balloon occlusion (Fetendo
balloon) because of high morbidity resulting from tracheal dissection
required to place the clips. These techniques appeared to result in
augmented lung growth (Harrison ef a/. 2003), and a NationalInstitutes of
Health (NIH) randomized controlled trial ensued. However, fetal tracheal
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ligation did not prevent the development of pulmonary hypoplasia in
human CDH (Harrison et al. 2003), nor did it improve survival or
morbidity rates (Heeremaef al. 2003). Radiographic increases in lung size
achieved with fetal tracheal occlusion may have been in part due to
emphysematous change and fluid pooling. Human fetal programmesin
North America and Europe continue to investigate fetal endoscopic
techniques reserving them for fetuses considered at the highest risk:
however selecting such cases remains problematic (Keller et al. 2004;
Deprestet al. 2005; Saura et al. 2007).
1.1.8 Outcome
Survival rates are hard to determine due to ‘hidden mortality’ i.e. antenatal
and early postnatal deaths prior to transfer to the definitive paediatric
surgery centre (Beresford et al. 2000; Stege et al. 2003; The Ontario
Congenital Anomalies Study Group 2004; Colvin et al. 2005; Dillonegai.
2000). Many dedicated centres now report 80-90% survival for CDH
(Wilson et al. 1997; Boloker et al. 2002; Kays et al. 1999; Wungetal.
1995). However, when the ‘hidden mortality’ is considered it appears that
mortality remains as high as 60% (Beresford et al. 2000; Stege et al. 2003).
In addition, centres performing more than 5-6 cases per year appear to
achieve better survival compared with smaller-volumecentres (Skari ef al.
2004).
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In long-term follow-up studies of children requiring ECMO,either priorto,
or following CDHrepair, a proportion suffer from significant hearing loss,
the aetiology of which is not clear (Rasheed et al. 2001; Robertson etal.
1998); others exhibit mild neuromotor and cognitive delay in their
development (Ahmadet al. 1999; McGahrenet al. 1997; Lund et al. 1994).
A proportion of patients remain oxygen dependent, some being affected by
chronic lung disease and infection (Schoeman et al. 1999). Many have
problems with growth and nutrition. Gastro-oesophageal reflux, possibly
related to diaphragmatic dysfunction may often require fundoplication
(Kieffer et al. 1995).
1.2 Lung development
Human lung developmentbegins during the fourth week of gestation when
the lung bud formsas a ventral outgrowth of the foregut; the process is
held to conclude during early childhood (Boyden 1977).
Although investigators have studied the human lung, much of our
understanding of pulmonary development has arisen from the study of
animal models due to their availability and accessibility. The ability to
create genetic knock-out and knock-in models has permitted the function
of several genes andtranscription factors to be elucidated. Despite the
duration / timing of the stages of pulmonary development differing
between species, it appears that the major mechanisms of development are
26
well conserved, such that insights gained from animal models, including
invertebrates such as Drosophila melanogaster, can be cautiously
translated to the human fetal lung (Ghabrial et al. 2003).
1.2.1 The mature lung
Normal lung development is complete by approximately 2-3 years ofage.
At completion, there are 300-600 million alveoli, approximately 1000 per
acinus (Thurlbeck 1982). The adult lung contains more parenchymal air
spaces (86.5% in the adult vs. 74% at birth), less tissue (13.5% in the adult
vs. 26% at birth), but much morecapillary blood (42% in the adult vs. 16%
at birth) (Zeltner et al. 1987a; Zeltner et al. 1987b; Gehr et al. 1978; Crapo
et al. 1982). Lung development and growth represent well-balanced
processes which occur in keeping with the requirements of the organism
for an adequate and undisturbed supply of oxygen.
1.2.2 Morphological stages of lung development
Five stages of pulmonary development (Figure 1.4) have been described:
(1) the embryonic period, (2) the pseudoglandular stage, (3) the canalicular
stage, (4) the saccular stage and (5) the alveolar stage (Zeltner ef al.
1987a). Some of these phases overlap and their duration / timing differ
between species.
During the fourth week of human gestation, the laryngotracheal grooves
appear laterally on both sides and deepen, such that the lung bud begins to
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Figure 1.4. Stages of human lung development. Adapted from
Zeltneret al. 1987a.
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separate from the oesophagus. Following elongation of the lung bud, it
divides dichotomously and invades the surrounding mesenchyme,
whereupon it undergoes further dichotomous branching (Figure 1.5).
Epithelial-mesenchymalinteractionsplay critical role (see section 1.2.3)
in regulating lung development (Alescio et al. 1968; Taderera 1967;
Spooneref al. 1970; Wessells 1970; Metzger et al. 2008).
During the pseudoglandular phase, the developing lung undergoes further
stereotypical branching and vascular development such that at its
completion (week 17 in the human fetus), the patterning of the preacinar
airways and vasculature matchesthat of the adult lung.
The canalicular stage is characterised by gas-exchanging tissue becoming
visible under the light microscope (Boyden 1977), the lung parenchyma
being ‘canalised’ by capillary development, and surfactant production
commencing.
During the saccular stage, the peripheral airways distal to the terminal
bronchioles lengthen and widen, the last generations of air spaces are
formed, and the peripheral airways form groups of widened air spaces
called saccules. As a consequence, the future gas-exchanging regions
increase exponentially.
Finally, the human lung enters the alveolar stage at around week 36 of
gestation, which is completed by 18—24 monthspostnatal age (Langston er
al. 1984). During this stage, the alveoli are formed and the capillary
network becomessingle layered.
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 Human 4 4.5 5.5 weeks
Rat 12.5 13.5 14.5 days
Figure 1.5. Human lung development begins during the fourth week
of gestation when the lung bud (black) formsas a ventral outgrowth
of the foregut (yellow). Following elongation of the lung bud,it
divides dichotomously and invades the surrounding mesenchyme
(red), whereupon it undergoes further dichotomous branching. Lung
development occurs in an analogous mannerin therat, albeit, over a
different time frame. Figure courtesy of Mr Edwin Jesudason,
Consultant Paediatric Surgeon, The Royal Liverpool Children’s
Hospital, Alder Hey (adapted from Larson et al. Human
Embryology).
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1.2.3 Epithelial-mesenchymal interactions in the developing
lung
Lung morphogenesis is complex; the process is tightly regulated by a
genetic programme (which involvestranscription factors, growth factors,
epithelial-mesenchymalinteractions and hormones). These factors interact
along the proximal-distal axis ofthe respiratory tract and direct endodermal
patterning, lung branching morphogenesis, left-right asymmetry and
vascular development (Coplandet al. 2004).
It is only possible to briefly review some of these factors in this
introductory chapter. Epithelial-mesenchymal interactions are central to
branching morphogenesis (Masters 1976; Bluemink et al. 1976). Factors
such as hepatocyte nuclear factor-3 beta (HNF3B [foxf2a]) (Zhou et al.
1996; Zhou et al. 1997), GATA binding protein 6 (GATA-6) (Keijzeretal.
2001), thyroid transcription factor-1 (TTF-1 [Nkx2.1]) (Zhou et al. 1996;
Ikeda et al. 1995; Kimura et al. 1996) and Iroquois homeobox genes (Irx)
(van Tuyl ef al. 2006) are found within the epithelium and regulate
epithelial specification. Members of the Gli gene family, Gli2 and Gli3
(Motoyamaef al. 1998; Quaggin et al. 1998) and basic-helix-loop-helix
proteins, Pod-1 (Quaggin et al. 1998) are located in the mesenchyme and
control epithelial patterning. A number of morphogens are produced by the
epithelium and mesenchyme; sonic hedgehog (Shh) (Miller et al. 2001;
Urase et al. 1996) and platelet-derived growth factors (PDGFs) (Buchet al.
31
1991) are produced in the epithelium while fibroblast growth factors
(FGFs) (Lebeche et al. 1999) and epithelial growth factors (EGFs)
(Ruocco ef al. 1996) are mainly produced by the mesenchyme. Shh
(Pepicelli ef al. 1998) and fibroblast growth factor 10 (FGF10) (Sekine et
al. 1999)play a crucial role in branching morphogenesis.
Vascular development is likewise controlled by a number of growth
factors, transcription factors, cell-extracellular matrix and cell-cell
interactions. Vascular endothelial growth factor (VEGF) (Healy ef al.
2000; Bhatt et al. 2000; Gebb et al. 2000), angiopoietin (Colen et al. 1999;
Koblizek et al. 1998; Maisonpierre et al. 1997) and ephrin families (Hall et
al. 2002) have been implicatedin its regulation.
1.2.4 Mechanical factors in the developing lung
It is now evidentthat the process of lung growth and development not only
requires a genetic programme but also manyphysical factors. A variety of
physical factors have been implicated in lung development: (i) lung liquid
secretion by the pulmonary epithelium (Alcorn ef al. 1977; Fewell et al.
1983), (ii) retention of lung liquid by the fetal glottis and upper airways
resulting in a positive intraluminal pressure (Vilos ef al. 1982; Harding er
al. 1986), (iii) fetal breathing movements (Kitterman 1986), (iv)
maintenance of sufficient intrathoracic and amniotic liquid volumes
(Harrison et al. 1980b; Potter 1946) and more recently, (v) airway
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peristalsis (spontaneouscontractility of the prenatal airways) (Jesudason et
al. 2005).
Drainage of lung liquid by tracheostomy in fetal lambs results in
pulmonary hypoplasia; conversely, tracheal ligation results in lung growth
and pulmonary maturation (Alcorn et al. 1977; Fewell et al. 1983). These
experiments alter both intraluminal liquid volumes and_ pressures;
therefore, lung liquid secretion and maintenanceofa positive intraluminal
pressure may be interrelated in their effects. In a similar manner,
congenital laryngeal obstruction in the fetus results in hyperplastic lungs
dueto the retention of lung liquid (Griscom ef al. 1969; Silver et al. 1988).
Fetal breathing movements begin as early as the eighth week of gestation
in the human fetus and continue until parturition (de Vries et al. 1986).
They result in changes in intrathoracic volume which prevent lung liquid
loss from the developing lung (during periods of upper airway relaxation
and glottic opening) and may also distend the developing airspaces
(Harding 1991). When fetal breathing movements are abolished through
phrenic nerve section, cervical cord lesions, or neurological conditions, the
resulting lung is hypoplastic (Wigglesworth et al. 1979; Goldstein et al.
1980; Liggins ef al. 198la; Liggins et al. 1981b). Fetal breathing
movements therefore provide mechanical signals that influence lung
growth and development.
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1.3 Airway smooth muscle andperistalsis
1.3.1 Airway smooth muscle development
Pulmonary development commences on embryonic day 10 (E10) in the
mouse; the two lung budsarise from the foregut (Spooneret al. 1970; Ten
Have-Opbroek 1981). During the following days (E11-14) the lung
undergoes dichotomousbranching (branching morphogenesis) to form the
bronchial tree. Airway smooth muscle (ASM) becomes apparent on day
E11; parallel bundles of ASM cells are arranged circumferentially around
the long axis of the airways andstain positively for a-smooth muscle actin
and calponin (Tollet et al. 2001). At branch points, airway smooth muscle
fibres bend or curve around the tubules following the structural contours.
At higher magnification, the bundles do not constitute a continuous sheet,
but intermittently cross over to join neighbouring bundles. However, the
layer is continuous, forming a syncitium or meshwork of interlocking
airway smooth muscle over the developing lung.
ASM cells develop from the mesenchyme directly underlying the
epithelium at the base of the epithelial buds (Sparrow et al. 2003; Mailleux
et al. 2005). Initially, the newly formed ASM bundles form a thin ring
around the base of the epithelial bud. As the epithelial tubule progresses
into the mesenchyme, new cells are added distally. In general, smooth
muscle myogenesis requires transformation of mesenchymalcells into SM
myoblasts; these subsequently become immature SM cells (Mitchell et ai.
1990; Wright et al. 1999). Mesenchymalcell shape plays a strong role in
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visceral myogenesis; if mesenchymalcells are plated under conditionsthat
maintain cell rounding or permit elongation, it is those cells that elongate
that differentiate into smooth muscle (Yangef al. 1999).
The interlocking nature of the smooth muscle bundles permits electrical
continuity and mayfacilitate coordinated rhythmic contractions of the
tubules via low resistance gap junctions (Sparrow ef al. 2003). The
circumferential arrangement of airway smooth muscle provides radial
stiffness and the discontinuity of neighbouring bundles may assist
longitudinal extensibility, helping length changes that occur during
spontaneousnarrowing (Sparrow et al. 2003).
Stretch appears to be a prerequisite for smooth muscle myogenesis
(Schuger 1997; Yang et al. 1998; Zhang et al. 1999; Yang et al. 1999;
Yang et al. 2000). Mesenchymalcells need to spread on their basement
membranes. Blocking laminin polymerisation prevents the spread of
mesenchymalcells and abolishes synthesis of smooth muscle cell proteins
(Schuger 1997; Yang ef al. 1998; Zhang et al. 1999). Serum response
factor (SRF) may induce the expression of smooth muscle-specific proteins
within mesenchymalcells (Belaguli et al. 1997; Kim et al. 1997; Browning
et al. 1998). Sustained stretch induced by increasing intraluminal pressure
using dextrans in cultured mouse lungs results in an increase in the
production of SRF in favour ofits inhibitory isomer SRFAS (Yanget al.
2000). When SRFASis over-expressed under the same conditions, stretch-
induced myogenesis was blocked (Yanget al. 2000).
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1.3.2 Spontaneousairwaycontractility (airway peristalsis)
Airway smooth muscle is a central component of the developing lung.
Spontaneously contractile (Figure 1.6) throughout gestation; it is
pharmacologically responsive at an early stage. Its phasic activity is
associated with maintenance ofa positive intraluminal pressure within the
developing lung (McCray 1993). This positive pressure may act as a
stimulus to lung growth via forces applied across the airway wall and
neighbouring parenchyma. This activity may also be central to smooth
muscle myogenesis.
Spontaneous smooth muscle contractility was first noted in the fetal airway
and air sacs within chick embryos and cultured chick lung explants;
contractility was temperature dependent, had a frequency of ~2 per minute
at 38°C and occurred without histological evidence of innervation (Lewis
1924). Schopper reported similar findings in chick and guinea pig lung
explants (Schopper 1935; Schopper 1937). Solman et al. reported
spontaneous airway smooth muscle activity in preparations from puppies
and midgestation human fetal lung (Solmann ef al. 1937). They also
documented the pharmacologic responses to adrenergic and cholinergic
stimuli and other agents.
Sparrow et al. described spontaneous contractility in fetal pigs and the
responses to a range of pharmacological agents; prenatal airways
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Figure 1.6. Airway peristalsis in embryonic lung. View clockwise
from top-left. Epithelium (E) in dashed box constricts in panels 2 and 3
before relaxation. t-=trachea; b=end-bud; R=right; L=left. Images
courtesy of Miss Nikki Smith, The Royal Liverpool Children’s
Hospital, Alder Hey.
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contracted in response to application of acetylcholine, depolarising high-K*
solution, histamine and substance P (Sparrow et al. 1995). The B-
adrenergic agonist, isoprenaline, relaxed the airways and abolished
spontaneous contractility (Sparrow ef al. 1995). Verapamil, a Ca™*
antagonist, similarly abolished spontaneouscontractile activity (Sparrow et
al. 1995).
Schittny ef al. investigated spontaneous contractility in fetal pigs and
rabbits, noting spontaneous contractility throughout gestation, to within
100 um of the terminal sacs (Schittny et al. 2000). Contractility was
transient, initiating in one part of the bronchial tree before subsiding and
beginning in anotherportion.
Spontaneous airway contractility also occurs in vitro. Sorokin noted that
spontaneousairway contractions were presentin rat lung cultures after 2-3
days and considered that distension of the terminal buds produced by such
contractions might relate to pulmonary development (Sorokin 1961).
Sparrow ef al. documented contractility in pig lung explants (Sparrowetal.
1994). Roman and Schittny ef al. noted spontaneouscontractility in mice
(Roman 1995; Schittny ef al. 2000). McCray noted spontaneous
contractility in human fetal lung tissue when cultured (McCray 1993).
Epithelial tubules were spontaneously contractile and could be contracted
by cholinergic agents (acetylcholine), dilated by  adrenergics
(isoprotenerol) and the contractions reduced or abolished by Ca”
antagonists (cadmium chloride or nifedipine) or activation of potassium
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channels (lemakalim) (McCray 1993). Abolition of spontaneouscontractile
activity using Ca’" antagonists suggested it requires Ca”* influx via
voltage-operated channels (McCray 1993). Fetal airway smooth muscle
must contain functional cholinergic receptors given that carbachol
application resulted in an increase in contractility and tetany (McCray
1993). Isoprotenerol application resulted in relaxation (McCray 1993)
suggesting that the sympathetic nervous system or circulating
catecholamines could affect fetal airway contractility. Lemakalim activates
K* channels in adult airway smooth muscle, resulting in relaxation of
carbachol-induced contractions; here (McCray 1993) it abolished airway
contractility and carbachol-induced tetany suggesting K” channels are also
involved in the control of spontaneous activity. Contractile activity
originated from within the same region in explants, generally propagated in
a proximal to distal direction, and occurred regularly (inter-contractile
interval 54 + 5 sec (mean + SEM)) (McCray 1993). Contractile strength
was variable; sometimes contractions were easily seen, but at other times
could only be documented on video recordings played at high speed
(McCray 1993).
Contractile activity is highly temperature dependent as first noted by
Margaret Reed Lewis (Lewis 1924). McCray similarly documented a
gradual weakening of contractile force and increase in the inter-contractile
interval upon cooling from 37°C to 22°C (McCray 1993).
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Given that airway smooth muscle contractility has been documented
throughout gestation in several species in embryos, cultured fetal lung
explants and isolated smooth muscle preparations, it suggestsit is a highly
conserved mechanism and supports the thesis that such activity is a
physiological function of the developing lung in vivo.It also suggests that
contractility is not an artefact of the culture system.
In vitro, spontaneouscontractility begins within 24 hours and is evident by
the airways narrowing over short distances (McCray 1993; Roman 1995;
Jesudason et al. 2005). By 48 hours, strong airway contractions are
propagated from the central tubules to the periphery (Schittny et al. 2000).
Embryonic ASM contractility is phasic, contrasting with its postnatal tonic
activity (Boyle et al. 1992; Somlyo et al. 1994; Bergner ef al. 2002).
Similar to peristalsis within the gastrointestinal tract, prenatal mechanical
contractility of airway smooth muscle may bedriven by bursts of action
potentials (Featherstone et al. 2005).
Contractility is peristaltic-like, propelling lung liquid through the principal
airways and distending the distal buds. Perhaps this spontaneousactivity is
not so surprising given the common embryological origin of the lung and
the gastrointestinaltract.
Video-microscopy has permitted airway peristalsis to be quantified in the
lungs of fetal pigs and rabbits, and murine lung explants (Schittny ef al.
2000). Airway narrowing was reported to occur intermittently (lasting for
several minutes) in the large and small diameter tubules; the luminal
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diameter reducing to as much as 46% ofthe relaxed size. The peristaltic
wave was propagated over several generations of airways in a proximal to
distal direction.
Although the embryological lung contains nerve fibres, spontaneous
contractility occurs even in the presence of atropine (cholinergic
antagonist) or tetrodotoxin (an inhibitor of sodium currents in excitable
cells and action potentials that are dependent on sodium ion influx),
demonstrating that the activity is myogenic,i.e. the activity arises from the
muscle itself or potential tetrodotoxin-insensitive pacemakercells (McCray
1993; Sparrow ef al. 1995). In some smooth muscles, spontaneousactivity
is generated from groups of smooth muscle cells (Lang et al. 2006; Lang et
al. 2007). In others, such as the gastrointestinal tract, it arises from the
interstitial cells of Cajal (Der-Silaphet et al. 1998; Ward et al. 2001), and
recently it has been shown that some smooth muscle activity appears to
originate from Cajal-like cells (Metzger et al. 2004; Ciontea et al. 2005;
McHaleet al. 2006; Lavoie et al. 2007).
The prenatal airway smooth muscle is pharmacologically responsive
(similar to postnatal airway); embryonic airways narrow rapidly to within
80 um of the epithelial buds in response to acetylcholine and histamine
(Sparrow ef al. 1994; Sparrow et al. 1995). Electrical field stimulation
(EFS) also results in rapid narrowing mediated by cholinergic innervation
as it is reversibly blocked by both atropine and tetrodotoxin, but not
hexamethonium (Sparrow ef al. 1994). Prenatal airway smooth force
4]
generation is comparable with postnatal ASM when normalised for ASM
content (Booth et al. 1992).
Spontaneous contractility of the embryological airways results in
mechanical stretching or distortion of the fetal pulmonary epithelium
(Sparrow ef al. 2003). Mesenchymal cells adherent to the basement
membrane within this region would consequently be stretched and then
relax as the lung liquid returned centrally with dilatation of the principal
airways. Wirtz and Dobbsreported that a single mechanical stretch of adult
rat alveolar type II cells resulted in a release of surfactant and a sustained
increase in intracellular calcium, and suggested that phasic distension of
the alveolar epithelium is a mechanical signal for surfactant release
mediated via calcium-induced exocytosis (Wirtz et al. 1990).
Phasic lung distension within the embryological lung may provide a
mechanical signal that governs growth factor release, signalling molecules
or gene expression, resulting in lung growth. ASM tone may be
responsible for the maintenance of a positive intraluminal pressure within
the fetal lung (McCray 1993). If the ASM lacked tone, the airway wall
would be compliant and distend with the secretion of lung liquid during the
fetal period. Airway peristalsis may also serve to maintain an even
positive-pressure within the developing lung or to prevent cellular debris
from settling in any particular portion of the lung, hence preventing
obstruction (Sparrow ef al. 1994).
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Phasic mechanical stretching of fetal lung organotypic cultures orcells has
been shown to induce changes that may affect lung growth. For example,
intermittent stretch of fetal lung organotypic cultures or cells has been
shown to enhance prostacyclin production and increase cyclic adenosine
monophospahate (cAMP) production and increase lung growth (Skinneref
al. 1992; Liu et al. 1992). Mechanical stretch also increases expression of
extracellular matrix components, surfactant protein (SP) mRNAs (SP-A,
SP-B and SP-C) and parathyroid hormone-related peptide (Nakamuraet al.
2000; Sanchez-Esteban et al. 1998; Torday et al. 1998). It appears that the
cellular changes mediated by mechanical stretch may occur through
activation of the tyrosine kinase pp60°° and be mediated via phospholipase
C and protein kinase C (Liu efal. 1995; Liu et al. 1996). Thus it appears
that a pulsatile mechanical stimulus is better than static forces when
stimulating lung growth in vitro.
Asyet, it remains unclear as to whenthe transition occurs from a phasic to
tonic activity. If action potentials drive spontaneous airway contractility
(Featherstone et al. 2005), the airways will need to lose their capacity to
generate such activity if it is to become tonic. Perhaps, tonic activity may
result from increased autonomic activity from central neurones acting via
the vagus that increases with the approach of parturition (Featherstone et
al. 2005).
43
1.3.3 Airway peristalsis and lung growth
Recently, it has been demonstrated that airway peristalsis (AP) appears to
be coupled to lung growth in vitro (Jesudason et al. 2005). Modulation of
peristaltic frequency resulted in parallel changes in lung growth and vice
versa. Stimulation of lung growth using 5% fetal calf serum or the classical
morphogen FGF-10 resulted in increased frequency of airway peristalsis
(Jesudason et al. 2005). Increasing airwayperistalsis frequency using the
cholinergic agonist, nicotine (0.1 uM), resulted in increased lung growth
(Jesudason et al. 2005). Likewise, blockade of airway peristalsis using
nifedipine (5 uM) reduced lung growth (Jesudason et al. 2005). Inhibition
of lung growth using UO126 (a MEK1/2 inhibitor) impaired airway
peristaltic frequency (Jesudason et al. 2005). These data lend further
support to the thesis that airway smooth muscle may havea purpose rather
than purely being the ‘appendix ofthe lung’ (Mitzner 2004).
Further studies supporting this hypothesis have been published more
recently (Jesudason eft al. 2006). The nitrofen model of congenital
diaphragmatic hernia (see section 1.1.5) allows investigation of the
embryonic lung prior to closure of the diaphragm. These studies have
demonstrated that the hypoplastic lung exhibits abnormal smooth muscle
function and uncoupling of growth and airwayperistalsis.
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1.4 Ca**; signalling in smooth muscle
1.4.1 Smooth muscle
The majority of smooth muscle is located within the walls of hollow
organs and tubes of the body. Cells are spindle-shaped, have a single
nucleus and measure approximately 2-10 uM in diameter and 50-400 uM
in length (Stephens 2002). Cells are arranged in sheets throughout the
length ofthe muscle.
Smooth muscle cells contain three types of filaments: thick myosin
filaments, thin actin filaments and intermediate filaments (Stephens 2002).
Unlike skeletal muscle, smooth muscle filaments do not from myofibrils
and are not arranged in a sarcomere pattern. Thick myosin and thin actin
filaments are arranged obliquely within an elongated diamondlattice;
sliding of the thin filaments past the thick filaments results in cellular
contraction. During smooth muscle excitation, there is an increase in
intracellular Ca”* (Ca’*}). Ca’* binds with calmodulin and the resulting
complex binds to and activates myosin kinase, which in tum
phosphorylates myosin. This then binds with actin such that cross-bridge
cycling and contraction can begin (Stephens 2002).
Ca”* either enters the cell from the extracellular space (e.g. via voltage-
gated L-type Ca”* channels) or from the Ca’’; store, the sarcoplasmic
reticulum (SR). Smooth muscle relaxation is achieved through removal of
Ca’";; it is actively transported across the plasma membraneorreturned to
the SR via the SR Ca’*-ATPase (SERCA pump)(Sanders 2001; Taylor ef
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al. 2002). When Ca’*; is removed, myosin is dephosphorylated and muscle
relaxation occurs.
There are two main types of smooth muscle: multiunit or single unit
(Burnstock 1979). Multiunit smooth muscle is composed of multiple
discrete units that exhibit independent function. Each muscle subunit is
stimulated by nerves with resultant contraction (neurogenic action).
However, most smooth muscle is single unit (also known as visceral
smooth muscle) and located within the walls of tubular organs or viscera.
Gap junctions link the cells and allow the propagation ofaction potentials
throughout the muscle (functional syncitium) such that when cells become
excited, the muscle contracts as a whole (Hashitani et a/. 2001; Hashitani
et al. 2004). This form of smooth muscle is myogenic; specialised
pacemakercells generate spontaneousactivity (pacemakerpotentials)(Hirst
et al. 2003). Pacemaker cells spontaneously depolarize and initiate an
action potential which is then propagated throughout the muscle via gap
Junctions. Pacemaker cells are usually located at specific anatomical
locations within the muscle itself (Hirst et al. 2003). There is also an
intermediate category of smooth muscle (e.g. canine tracheal smooth
muscle) which has sparse innervation and few gap junctions (Burnstock
1979).
Normally, smooth muscle has sufficient baseline levels of Ca”*; to maintain
a low level of contraction (tension / tone). An increase in Ca’’; results in a
contractile response. Airway smooth muscle is also innervated by the
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autonomic nervous system which can enhance or inhibit contraction
(Stephensetal. 2002).
1.4.2 Ca”; sensors
Ca”*; dynamics and corresponding physiological phenomena have
interested researchers for over fifty years. Development of probes and
instrumentation has made this research a possibility (the relationship
between Ca’; and excitation-contraction coupling in a wide variety of
smooth muscle types has been investigated as a result). Probes need to be
able to measure the temporal andspatial changes of Ca’"; within cells and
tissues (ranging from nanomolar to micromolar concentrations) such that
the biological response to stimulation can be determined (Rudolf ef al.
2003).
Ca’* probes(indicators, reporters or sensors) are moleculesthat are able to:
(1) form selective and reversible complexes with Ca’ ions; and (2) exhibit
different physicochemical characteristics when bound / unbound. These
abilities permit the relative concentrations of free and bound probe(rather
than absolute Ca"; concentrations) to be measured.
For example, the excitation (or emission) spectra of the ratiometric dyes,
Indo-1 or Fura-2, as used in our studies alter according to the free Ca”*;
concentration (Grynkiewicz et al. 1985). The Ca”*, concentration is
measured as the ratio between the two fluorescence intensity values that
are obtained at two wavelengths (A; and Az). Ratiometric dyes are valuable
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as they correct for uneven loading, photobleaching and changesin the focal
plane (through movement) as the ratio does not rely on the absolute
intensity of the fluorescent signal. Non-ratiometric dyes, e.g. Fluo-4 as
used in our studies, measure the Ca", concentration through the relative
increase in fluorescence intensity upon an increasein free Ca’; (Geeet al.
2000). However, these dyes are more susceptible to photobleaching and
movementartefact.
Absolute Ca”*; concentration can be calculated through measurementofthe
maximalor minimal fluorescence (Fmax and Fmin respectively) necessitating
exposure of the loaded cells or tissue to a known Ca” concentration via
biochemical methods, e.g. ionophores (Kao 1994). These techniques are
often incompatible with cell or tissue survival.
Thefirst dyes were discovered during the 1960’s and 1970’s; the spectral
properties of the organic coloured compounds murexide, the azo dyes and
chlortetracycline were noted to change upon binding Ca’* (Rudolf er al.
2003). However, it was not until the late 1970’s that the first rationally
designed fluorescent Ca”* probe was synthesised for intracellular use
(Tsien 1980). The prototype polycarboxylate dye (BAPTA) was a
derivative of the Ca** chelator EGTA; Ca’* binding resulted in structural
changes/ alteration of spectral properties (Tsien 1980). This group of dyes
gained popularity as synthesis of their acetoxymethyl (AM) esters
permitted trapping of the dye within living cells, no specific technology
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was required to load cells or tissues, and they were effective in most cell
types with minimalside effects (Tsien 1981).
In the 1960’s, aequorin (AEQ) and green fluorescent protein (GFP), were
discovered during investigation of the medusa Aeguorea victoria
(Shimomura etal. 1962; Moriseet al. 1974). These proteins have impacted
greatly upon Ca”*; signalling research during recent years. Cloning ofAEQ
complementary DNA has permitted recombinant expression of AEQ
protein in heterogeneous systems (Prasher ef al. 1985). Probes can be
targeted to specific cellular locations by the insertion of specific signal
sequencesinto cells, or to specific proteins such that their spatio-temporal
distribution and interactions can be studied (Rizzuto et al. 1992; Rizzuto et
al. 1994).
Similarly, recombinant probes based on GFP were developed after it was
demonstrated that heterogeneously expressed GFP maintains its strong
fluorescence upon excitation in cells (Chalfie et al. 1994; Miyawaki etal.
1997; Romoseret al. 1997). These probes, of which there are three main
types (“cameleons’, ‘camgaroos’ and “pericams’) use calmodulin (CaM)as
a molecular switch, which changes its conformation on the binding of Ca”*
(Miyawaki ef al. 1997; Baird et al. 1999; Nagai et al. 2001). These
conformational changes alter the fluorescence properties permitting
calculation of [Ca”*;]. However, CaM is important in many physiological
processes, and its over-expression within cells may alter Ca’*;-dependent
reactions. As a consequence, transgenic models expressing GFP probes
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have been only described in lower organisms e.g. Drosophila (Diegelmann
et al. 2002; Fiala et al. 2002; Reiff et al. 2002; Yu et al. 2003). Ca’*;
imaging using CaM-GFP probes mayalso be affected by photobleaching
of GFP and the loss of kinetics of the conformational changes of CaM
uponthe binding of Ca’*.
These techniques may permit the analysis of highly complex organisms
and perhapsin time, whole living organisms. To undertake this, it will not
only require the development of new probes, but also instrumentation (e.g.
camera systems, filters, software and hardware) that will permit their
investigation. The genetically encoded probes are becoming more popular
as genetic manipulation readies the organism for in vivo Ca’"; signalling
studies.
1.4.3 In-situ Ca”’; signalling
Ca’*; sensitive indicators are most often used in single cell preparations
necessitating enzymatic digestion. More recently, it has been possible to
perform imaging of structures without enzymatic treatment or extensive
dissection (Burdyga ef al. 2003). These preparations are perhaps ‘more
physiological’ as they retain cell to cell contact with neighbouring tissue
rather than being isolated. Through pioneering techniques it has been
possible to image larger structures (e.g. mouse lungs and brain) through
tissue slicing techniques (Bergneref al. 2002; Yuan et al. 2007).
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1.5 Closing remarks andaimsof the thesis
This study aims to investigate the basic biology of spontaneous fetal
airway smooth muscle contractility. Firstly, it aims to study the
mechanisms underlying this physiological activity and secondly, to relate
them to lung growth in normal development and hypoplastic lung
development (the nitrofen model of lung hypoplasia). Thus far, there is
good evidence to suggest that spontaneous airway contractility requires the
entry of extracellular calcium (Ca’*,) via voltage operated channels and
that AP may be regulated via K” channels. We aim to specifically test
whether AP is underpinned by Ca’’; activity, and if so, the role of Ca’*,
- . . .entry and Ca”’; releasein its generation.
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Chapter 2
METHODS
a2
2.1 Introduction
CDH has an incidence of approximately 1 in 2500 births and despite
advances in healthcare mortality remains as high as 60% (Stege et al.
2003). The majority of these deaths result from the associated pulmonary
hypoplasia and accompanying pulmonary hypertension (Skari et al. 2000).
Accordingly, many researchers have chosento investigate early pulmonary
development in order to gain insights into factors that influence pulmonary
growth. To undertake these studies, a variety of techniques are required;
some are already well-established (e.g. lung culture) whilst others (e.g.
confocal and photometric measurement of Ca’’;) have been used with
success in other tissues, but require innovative ideas and refinement to
permit their use in small tissues such as the embryonic lung (< 1mm
diameter).
This study aims to investigate the basic biology of spontaneous fetal
airway smooth muscle contractility with particular emphasis on Ca™*
signalling. The work necessitates knowledge of organ culture techniques,
Ca**-sensitive dyes and imaging techniques.
2.2 Materials and methods
2.2.1 Embryonic lung culture
Morphological development in vitro depends on the physiological
conditions (Nogawaet al. 2002). Consistent adhesionis essential to ensure
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reproducible branching morphogenesis. We have utilised translucent
polytetrafluorethylene membrane culture-dish inserts (Millicell, Millipore
Corp, Bedford, MA)for these reasons (Figure 2.1). Reproducible adhesion
is achieved and lungs undergo branching morphogenesis in a pseudo 2-
dimensional manner. Lungs are supported by the membraneand bathed by
medium on their undersurface at 37°C in 5% CO) for periods up to 78
hours; oxygenation occurs by diffusion. Translucency of the membrane
permits photography (Figure 2.2) and subsequent morphometric analysis
(Figure 2.3) using computer software (specimen perimeter, specimen area
and total bud count). The membrane also permits easy loading of explants
with calcium sensitive dyes prior to undertaking confocal and photometric
measurements of Ca",
Other investigators have utilised alternative methods for organ culture,
these include pre-scratching of plasticware to allow adhesion of explants or
their submersion within collagen gels (Gross et al. 1983; McAteerefal.
1983). However, previous experience of these techniques showed
unacceptable variation in branching morphogenesis (Jesudason 2001).
Lung branching morphogenesis within collagen gels occurs in a 3-
dimensional manner whichresults in difficulty in quantifying lung growth
and division. Furthermore, 3-dimensional growth may impair the ability of
lung explants to be optically sectioned using confocal microscopy and
finally, submersion within collagen gels would impair the ability to load
with Ca”, sensitive indicators.
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culture dish
 
membrane medium
Figure 2.1. Schematic diagram of the lung culture system. Lung
rudiments were positioned on translucent polytetrafluorethylene
membrane culture-dish inserts with serum-free culture medium
incorporating penicillin (100 IU/ml) and streptomycin (100 pg/ml).
Lung explants were incubated at 37°C in 5% CO)for periods up to 78
hours. Diagram courtesy of Mr Edwin Jesudason, Consultant
Paediatric Surgeon, The Royal Liverpool Children’s Hospital, Alder
Hey.
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Figure 2.2. Photomicrograph of an embryonic rat lung following
microdissection. The trachea (T), left lung bud (L) and right lung
bud (R) are shown. The scale bar shows 250 um. Image courtesy of
Mr Edwin Jesudason, Consultant Paediatric Surgeon, The Royal
Liverpool Children’s Hospital, Alder Hey.
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Figure 2.3. Lung morphometry. Scion Image Beta 4.03 software
(Scion Corporation, Frederick, Maryland, USA) was usedto trace
the epithelial contour (red line) around each image of cultured lungs
in order to calculate the individual lung epithelial area and perimeter.
The numberofterminal buds was also recorded (as shown).
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Alternative tissues (sheep or rabbit) could have been considered for
investigation in these studies. However, the rodent model was favouredas:
1) the model is well-established in our laboratory; 2) nitrofen (2,4-
dichloro-4’-nitro diphenyl ether) can be administered to pregnant rats on
day 9.5 of gestation to generate embryonic lung hypoplasia permitting
comparison between controls and hypoplastic lungs (Kluth et al. 1990;
Kluth et al. 1993; Kluth et al. 1996a; Kluth et al. 1996b); and 3) the small
size of the lungs (< 1 mm in diameter) permits the whole lung to undergo
confocal imaging ofintercellular Ca’*; waves. Should the ovine or rabbit
models of CDH have been used, it would have not been possible to image
the whole of the embryonic lungs (as we have been able to do in these
studies) and research would have beenlimited to sections of airway. Given
the larger size of the lungs of these species, it may not have been possible
to optically section them as to the same extent as rodentlungs. Finally, the
numbers in experimental cohorts would have beenless than with the rodent
model as it is expensive to maintain the stock and perform antenatal
surgery in order to create CDH.
2.2.2 Ca’*; sensitive indicators
The ratiometric dyes Indo-1 AM (Figure 2.4) and Fura-2 AM were chosen
for photometric studies and the non-ratiometric dye Fluo-4 AM (Figure
2.5) for confocal imaging. The excitation (or emission) spectra of the
ratiometric dyes (Indo-1 or Fura-2) alter according to the free Ca”;
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concentration; they were invaluable for these studies as they correct for
uneven loading, photobleaching and changes in the focal plane (through
movement) as the ratio does not rely on the absolute intensity of the
fluorescent signal. As a consequence, prolonged investigations (e.g. 90
minutes) examining the responses of lung explants to a variety of
pharmacologic agonists / antagonists could be undertaken with no loss of
signal. Non-ratiometric dyes (e.g. Fluo-4) measure the Ca”*; concentration
through the relative increase in fluorescence intensity upon an increase in
free Ca’*;. However, these dyes are more susceptible to photobleaching and
movement artefact. As a result measurement of Ca”: transients were
limited to not more than 90 seconds to reduce the effects of
photobleaching. However, Fluo-4 AM was essential to the ability to
perform simultaneousin-situ measurement of Ca’’; signals in ASM within
whole embryonic lung explants.
The acetoxymethyl (AM) esters permit trapping of the dye within living
cells; no specific technology is required to load cells or tissues (Tsien
1981) (Figure 2.6). These dyes have been previously reported to be
effective in most cell types with only minimal side effects.
Lungs were cultured for 54 or 78 hours before loading with Ca", sensitive
indicators. Following loading (see subsequent chapters for full details) the
explants were allowed to equilibrate for 30 minutes in physiological saline
solution at 37°C for washing and de-esterification of the dye.
Alternative techniques that could have beentheoretically considered for
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Figure 2.4. Schematic diagram depicting the molecular structure of
Indo-1 AM.
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Figure 2.5. Schematic diagram depicting the molecular structure of
Fluo-4 AM.
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Figure 2.6. Schematic diagram of the processes involved in loading
cells using membrane-permeant acetoxymethyl (AM)ester derivatives
of fluorescent indicators, in this case fura-2. Note the generation of
potentially toxic by-products (formaldehyde andacetic acid).
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measurement of Ca’’; include targeting of recombinant probes based on
AEQ or GFPto developing ASM (Prasheref al. 1985; Rizzuto et al. 1992;
Rizzuto et al. 1994; Chalfie et al. 1994; Miyawaki et al. 1997; Romoseret
al. 1997). Although this technique has been used with someeffect in the
sarcoplasmic reticulum ofrat tail artery (Rembold ef al. 1997), infection of
the embryonic ASM would necessitate generation of adenoviral vectors.
To design such a vector and successfully infect the ASM to permit
measurement of Ca’*, would be extremely technically challenging and
exceed the timescales available for this work. Additionally, the use of
adenoviral vectors could potentially alter the culture system and / or
spontaneouscontractile activity.
2.2.3 Perfusion chamber
Once loaded with Ca”"; sensitive dyes, the explants were secured within a
perfusion chamber. This provided stability (to reduce movementartefact),
allowed easy access to the tissue under study (should manipulation be
required during an experimental protocol) and allowed perfusion / rapid
exchange of solutions at a constant rate of known temperature. Lung
explants are of small size (<< 1mm diameter) necessitating development of
a custom-built chamberto fulfill these requirements. It was imperative that
any structure designed to hold the lung explants did not impair the
spontaneouscontractile activities noted during in vitro culture.
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Initially lung explants were placed on glass coverslips to determine
whether adherence would occur (Figure 2.7A). Specimens did not adhere
which resulted in their dislodgement during perfusion. Explants were then
placed below a coverslip (Figure 2.7B), however, this prevented their
perfusion and abolished visible peristalsis. As a result, explants were
placed under a coverslip supported by foil trivets (Figure 2.7C).
Reasonable stability was achieved, but again, some contractility was lost
through compression ofthe principle airways. It became evident that lungs
needed to be perfused without compression of the principle airways. Next,
lungs were left in-situ upon their polytetrafluorethylene membrane
culture-dish inserts and perfused from beneath (Figure 2.7D).
Unfortunately, this resulted in them being dislodged from their membrane
and uniform heating could not be guaranteed during experiments as only
their undersurface was in contact with the solution.
In answerto the above problems, a custom made chamber was designed
and built by myself, that utilised monofilament mesh to hold the lung
around its periphery without compressing the principle airways (Figure
2.7E). Similar perfusion chambers have been built by others to secure brain
slices or mouselung slices (Bergneret al. 2002), however these tissues are
much larger than embryonic lung (<< 1 mm diameter). This chamber
allowed submersion of the lung explants such that they were held securely
during perfusion and provided good visibility and access to the airways
such that confocal and photometric measurements of Ca’*; could be
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Figure 2.7. Development of the lung perfusion chamber. (A) Lung
explants were placed upon glass coverslips. Adherence failed to occur
and lungs were displaced when perfused (arrows). (B) Lung explants
were placed beneath glass coverslips. This prevented perfusion and
abolished visible peristalsis. (C) Lungs were placed beneath glass
coverslips supported on foil trivets. Stability was achieved, perfusion
could take place, but there was some loss of contractility through
compression ofthe principle airways. (D) Lungs wereleft in-situ upon
culture dish inserts. Explants lost their adherence during perfusion and
uniform heating could not be guaranteed. (E) The prototype perfusion
chamber used mesh to secure the periphery of explants, thereby,
avoiding compression of the principle airways. There was minimal
movement during perfusion and uniform heating was achieved.
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undertaken (Figure 2.8 and Figure 2.9). A variety of sizes of monofilament
meshweretrialled within the chamber assembly; 1000 um mesh provided
the best in terms of support andvisibility.
2.2.4 Confocal measurements of Ca”*;
Confocal imaging was used to determine the spatiotemporal characteristics
of intercellular Ca"; waves (Figure 2.10). Confocal microscopy provides
the ability to see inside relatively bulky specimens; as a result it can be
used to optically section the explants permitting visualisation of the ASM
surrounding the principle airways. It can focus on one specific tissue plane
rejecting out of focus light, resulting in high quality images, and it can be
used onliving tissues and cells as well as fixed tissues.
Image acquisition was possible from a large area (2.1 x 1.6 mm with the 4x
objective to 160 x 110 um with the 60x objective). This was beneficial as
the whole explant could be studied at low power to image intercellular
Ca**; waves (see chapter 3 and 4) andat high powerto search for the origin
of these waves. The imaging software permitted specific region(s) of
interest to be defined within the lung andthe fluorescence at this point(s) to
be determined over the time; this was particularly useful for interrogating
apparentinitiationsites.
There are a numberof disadvantages to confocal microscopy. Depth of
optical sectioning is limited by the light scattering properties of the tissue
itself, the amount of fluorescence quenched by overlying tissue and the
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Figure 2.8. Schematic illustration of the final perfusion chamber
assembly. The explant is secured by the mesh aroundits periphery
such that compression of the principle airways is avoided. A glass
coverslip forms the base of the chamber; it is held in position by
vacumn gel. The lung is perfused by a system that ensures constant
flow, temperature and rapid exchangeofsolutions.
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Figure 2.9. Photographs of the final perfusion chamber assembly.
(A) Superior aspect of the chamber. (B) Close-up of monofilament
that holds the lung around its periphery against the coverslip that
forms the base of the chamber. (C) Undersurface of the perfusion
chamber. The monofilament mesh is secured to the undersurface of
the chamber using superglue allowing regular replacement.
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Figure 2.10. Confocal imaging of intercellular Ca**; waves was
performed on an Ultraview LCI spinning Nipkow disc, widefield
Olympus IX70 inverted microscope (Perkin-Elmer Confocal
Microscope System, Cambridge, UK) with an ORCA ER cooled
CCD camera (Hamamatsu Photonics, Hamamatsu, Japan). Fluo-4
loaded explants were viewed at low power (4x objective, numerical
aperture (NA) 0.13; 10x objective, NA 0.17) or high power
magnification (60x water immersion objective, NA 0.9) and excited
by argon / krypton laser at 488 nm. Resulting fluorescence was
measured at 510 nm and was expressed as a function of maximum
comparedto basal values (F/FO).
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working distance of the objective lens. Tissue must be loaded with
fluorescent dyes to permit measurement of Ca’';; cells must remain viable
during imaging and dyes may load unevenly. The tissue is excited by an
argon / krypton laser at 488 nm andthe resulting fluorescence measured at
510 nm;relative Ca?*, is expressed as a function of maximum fluorescence
compared to basal values (F/Fo). Laser illumination results in
photobleaching and thus there is limited longevity to experimental
protocols; Ca’"; transients from each lung were observed for not more than
90 seconds. Lastly, movement artefact is a problem especially when
working at high magnification as the area under study may moveoutofthe
focal plane (x, y or z plane). Movementartefact is an inherent problem of
investigating spontaneously contractile tissue and attempts were made to
minimiseit through use ofthe perfusion chamber.
2.2.5 Photometric measurements of Ca”’;
To study Ca’*; waves andeffects of their modulation by temperature and
pharmacological agents, Ca’; signalling was also measured
photometrically using two ratiometric Ca”*; sensitive indicators, Indo-1 or
Fura-2. Dual channel ratioing techniques are used to measure Ca”*; when
using these dyes. Briefly, when Indo-1 was used, the photometric system
consisted of an Olympus [X50 inverted microscope (Olympus UK Ltd.,
London, UK) and Xenon lamp with an excitation wavelength of 340 nm
(Figure 2.11). Light emitted by Indo-1 loaded explants at 400 nm and 500
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Figure 2.11. Photometric measurement of Ca’’; signalling using Indo-
1. The photometric system consisted of an Olympus [X50 inverted
microscope and Xenon lamp with an excitation wavelength of 340
nm. Light emitted by Indo-1 loaded explants at 400 nm and 500 nm
was detected via photo-multiplier tubes (PMT) anddigitally recorded.
The ratio of the fluorescence signal (F400/500; 400 nm: 500 nm
emission) was used as an indicator of [Ca’"];. Ca’*, signals were
recorded using a 20x objective (N.A. 0.75) from the second bronchial
division ofthe right lung.
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nm was detected via photo-multiplier tubes and digitally recorded. The
ratio of the fluorescence signal (F400/500; 400 nm: 500 nm emission) was
used as an indicator of Ca’*.. Photometric measurements of Fura-2 loaded
explants employed a Cairn (Cairn Research Ltd., Faversham, UK)
monochromator with dual excitation (340 and 380 nm)andthe fluorescent
signals were measuredat 510 nm (F340380) (Figure 2.12).
Dual channel ratioing provides more reliable quantification (than single
channel measurement) as it is less susceptible to problems with dye loading
or movement artifact. As such, they became a useful tool in our
investigations as the embryonic lungs are spontaneously contracting and
movement artifacts can occur. Additionally, perfusion and exchange of
perfusion solutions can result in a certain amount of movement.
Photometric measurements of Ca”; are able to accommodate this whereas
confocal imaging is not. Additionally, photobleaching is less of a problem
with dual channel ratioing methods such that prolonged experimental
protocols could be undertaken.
2.3 Conclusions
a) Organ culture upon translucent polytetrafluorethylene membrane
culture-dish inserts permitted reproducible branching
morphogenesis, growth in a pseudo 2-dimensional mannerand easy
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Figure 2.12. Photometric measurement of Ca’*; signalling using Fura-
2. Photometric measurements of Fura-2 loaded explants employed dual
excitation (340 and 380 nm) and the fluorescent signals were measured
at 510 nm (F340/380). Ca’*; signals were recorded using a 20x
objective (N.A. 0.75) from the second bronchial division of the right
lung.
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loading with calcium sensitive indicators. Organ culture is well-
established in our laboratory permitting plentiful supply of
embryonic lung explants on which to perform measurements of
Ca”*,.
b) Ca”"; sensitive indicators (Indo-1 AM, Fura-2 AM and Fluo-4
AM)were chosen for these studies as their use is well-established,
require no specific technology to load the tissues, and have been
previously reported to be effective in most cell or tissue types with
minimalside effects.
c) Development of a novel perfusion chamber that secured the
embryonic lung without compressing the principle airways
permitted application of confocal and photometric techniques to
image and measure Ca’"; for thefirst time in whole embryonic lung
organ cultures.
d) Confocal microscopy permitted investigation of the
spatiotemporal characteristics ofintercellular Ca”*; transients within
whole lung explants. Experimental protocols were limited due to
photobleaching (imaging was limited to a maximum of 90 seconds
to minimise this). Movementartefacts are problematic when using
high power objectives as spontaneous contractility of the lung
explants resulted in specimens movingout ofthe focal plane.
e) Photometric measurements of Ca"; transients permitted
experimental protocols of long duration to be undertaken as
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photobleaching is less problematic. Additionally, these Ca”*
sensitive fluorescent dyes used dual channel ratioing techniques
which were beneficial as they are less susceptible to uneven dye
loading or movementartefact (compared to confocal measurements
of Ca”*}).
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Chapter 3
SPONTANEOUS PROPAGATING Ca**; WAVES
UNDERPIN AIRWAYPERISTALSIS IN
EMBRYONIC RAT LUNG
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3.1 Introduction
Every 24 — 48 hours in the United Kingdom,a child is born with CDH.
Historically, mortality was in the order of 40-60%, mainly due to
pulmonary hypoplasia and pulmonary hypertension (Smith et al. 2005).
Morerecently, several institutions have reported survival in 80-90% of
cases with the introduction of new ventilatory strategies and adjuncts
(e.g. permissive hypercapnea, inhaled nitric oxide, high frequency
oscillatory ventilation etc.) (Downardet al. 2003; Bagolan et al. 2004).
However, if ‘hidden mortality’ (in utero deaths, terminations of
pregnancy, postnatal deaths prior to transfer to the paediatric surgical
unit) are taken into account, mortality remains persistently high
(Beresford et al. 2000; Stege et al. 2003; The Ontario Congenital
Anomalies Study Group 2004; Colvin et al. 2005; Dillon et al. 2000).
Classical thinking suggested that pulmonary hypoplasia was secondary to
compression from the herniated abdominal contents. However, studies
undertaken during the last two decades have prompted reappraisal of these
concepts. Work undertaken in the nitrofen model of CDH suggests that
lung hypoplasia precedes closure of the diaphragm (Jesudason 2000;
Jesudason 2001; Jesudason 2002; Keijzer et al. 2000).
Given these contemporary views, many researchers have chosen to study
embryonic lung developmentin order to gain insight into the factors that
influence pulmonary growth. It is now well established that lung growth
not only requires a variety of growth factors, but also a number of
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mechanical factors (Hogan 1999; Harding et al. 1996). Spontaneous
contractility of the embryonic airways (airway peristalsis) is one such
mechanical factor that may be linked with pulmonary development
(Jesudason et al. 2005). Previous research suggests that Ca** influx in
ASM may be involved in its generation (McCray 1993; Roman 1995;
Sparrow et al. 1994).
We demonstrate that spontaneous propagating Ca”; waves underpin or
drive airway peristalsis. Given that airway peristalsis appears linked to
pulmonary growth and Ca’*; waves drive airwayperistalsis, this indicates
Ca’*; wavesdrive lung growth.
3.2 Materials and methods
3.2.1 Retrieval of embryonic lung primordia
In accordance with UK legislation, embryos from Sprague-Dawley rats
(Charles River Ltd, Margate, UK) were harvested on day 13.5 of gestation
(vaginal plug = day 0, term = day 22.5) as previously described (Jesudason
et al. 2000). This is 24 hours after the lung anlage formsas a diverticulum
from the foregut. Upon retrieval, embryos were transferred to an isotonic
saline bath cooled on ice. Microdissected from their extra-embryonic
membranes, embryos were secured in a lateral position using cranial and
caudal entomology pins. Using a Leica (Leica Microsystems (UK) Ltd.,
Milton Keynes, UK) MZ6_ stereomicroscope and microsurgical
instruments, a thoracic incision was performed to expose the embryonic
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heart and lungs. The heart was teased from the lung rudiments before the
oesophagus was freed carefully from the primitive carina. The trachea was
then sectioned and the pulmonary complex transferred by pipette into
serum-free culture medium (DMEM/F12 1:1, Gibco; Invitrogen Life
Technologies, Paisley, UK). Lung rudiments were positioned on
translucent polytetrafluorethylene membrane culture-dish inserts (Millicell,
Millipore Corp, Bedford, MA) with serum-free culture medium
incorporating penicillin (100 IU/ml) and streptomycin (100 ug/ml;
GibcoBRL, Life Technologies, Paisley, UK). Lung primordia were
incubated at 37°C in 5% CO)for periods up to 78 hours.
3.2.2 Assessmentofviability
Using bright field microscopy, specimens were inspected daily for
histological integrity, viability, and the periodic motion of luminal lung
fluid. Culture media were changed every 48 hours. Spontaneous airway
contractions were seen in 100% of explants by 48 hoursin vitro using this
established culture technique (Jesudasonet al. 2005).
3.2.3 Loading lung explants with Ca”*; sensitive fluophores
Lungs were cultured for 54 or 78 hours before 4 hour incubation at 37°C
with the membrane-permeant form of Fluo-4 AM (15 uM, Molecular
Probes, Invitrogen Life Technologies, Paisley, UK) with Pluronic F (for
confocal imaging), or 2 hour incubation at 37°C with the membrane-
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permeant forms of Indo-1 AM or Fura-2 AM (15 uM, Molecular Probes)
with Pluronic F (for ratiometric imaging of Ca’")). Explants were then
allowed to equilibrate for 30 minutes in physiologicalsaline at 37°C.
3.2.4 Confocal and photometric measurements
For confocal and photometric studies, lung primordia were secured in a
200 wl custom-made perfusion chamber by nylon mesh (Plastok,
Birkenhead, UK) that holds the lung periphery against the coverslip
without compressing principal airways.
Confocal imaging was used to determine spatiotemporal characteristics of
intercellular Ca". waves and performed on an Ultraview LCI spinning
Nipkow disc, widefield Olympus [X70 inverted microscope (Perkin-Elmer
Confocal Microscope System, Cambridge, UK) with an ORCA ERcooled
CCD camera (Hamamatsu Photonics, Hamamatsu, Japan). This permits
image acquisition from a large area (from 2.1 x 1.6 mm with 4x objective
to 160 x 110 um with 60x objective) at 20-30 frames per second with
relatively low intensity laser illumination and at good signal to noiseratio.
Fluo-4 loaded explants were viewed at low power (4x objective, numerical
aperture (NA) 0.13; 10x objective, NA 0.17) or high power magnification
(60x water immersion objective, NA 0.9) and excited by argon / krypton
laser at 488 nm. Resulting fluorescence was measured at 510 nm and is
expressed as a function of maximum comparedto basal values (F/Fo). To
reduce photobleaching, Ca’’; transients from each lung were observed for
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not more than 90 seconds. Propagation speedsof the Ca”*; and contractile
waves were measured using the Perkin-Elmer Microscope System.
Regions of interest were defined in the airways. Pixel counts between
regions of interest were then converted to distance (um) using calibration
measurements for each objective and pixel binning option. Measurement of
the interval (sec) between initiation of the Ca”; transient (or ASM
contraction) at one region of interest and the next allowed the propagation
speed to be quantified.
To study intracellular Ca’*; waves and effects of their modulation by
temperature and pharmacological agents, Ca”; signalling was also
measured photometrically using two ratiometric Ca”; sensitive indicators,
Indo-1 or Fura-2. The optical system has been described previously
(Burdyga et al. 1999). Briefly, when Indo-1 was used, the photometric
system consisted of an Olympus [X50 inverted microscope (Olympus UK
Ltd., London, UK) and xenon lamp with an excitation wavelength of 340
nm. Light emitted by Indo-1 loaded explants at 400 nm and 500 nm was
detected via photo-multiplier tubes and digitally recorded. The ratio of the
fluorescence signal (F400/s00; 400 nm: 500 nm emission) was used as an
indicator of Cr. Photometric measurements of Fura-2 loaded explants
employed a Cairn (Cairn Research Ltd., Faversham, UK) monochromator
with dual excitation (340 and 380 nm) and the fluorescent signals were
measured at 510 nm (F3493g0). With both indicators, Ca"; signals were
recorded using a 20x objective (N.A. 0.75) from the second bronchial
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division of the right lung (previously reported origin for most mechanical
contractions) (Jesudason ef al. 2005). For each lung primordia Ca’’;
transients were observed for at least 10 minutes. Temporal characteristics
of the Ca**; waves (duration of fast and slow phases, time to achieve 50%
of peak amplitude, amplitude, plateau duration, relaxation half-time (Tso)
and duration at 50% relaxation) were determined from at least three
representative transients per lung.
3.2.5 Solutions
Unless otherwise stated, lung explants were superfused at 37°C with
buffered physiological saline (pH 7.4) containing (mM): 120 NaCl, 5.6
KCI, 0.12 MgSO,, 2 CaCh, 11.7 glucose, 10.9 HEPES. ‘Zero Ca*”’
solution used in certain experiments consists of physiological saline with
CaCl, omitted and 2 mM EGTA added. Other additions to standard
superfusate that were investigated include: nifedipine (10 uM), Bay-K
8644 (1 uM), 18-8 glycyrrhetinic acid (18-BGA, 40 uM),
tetraethylammonium (TEA, 10 mM), cyclopiazonic acid (CPA, 20 uM),
caffeine (1 mM - 10 mM), ryanodine (20 uM), carbachol (10 uM -100
uM), 2-aminoethoxy-diphenylborate (2-APB, 50 uM)and high K” solution
(120 mM). Carbachol and ryanodine were dissolved in distilled water;
CPA, 2-APB and 18-BGA weredissolved in dimethylsulfoxide (DMSO),
whilst nifedipine and Bay-K 8644 were dissolved in ethanol (EtOH). Ca**;
wave generation and airway contractility were unaffected by applications
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of vehicle alone (DMSO or ETOH). Ryanodine was obtained from
Calbiochem (Merck Biosciences Ltd., Nottingham, UK). Sigma (Poole,
Dorset, UK) supplied all other chemicals.
3.2.6 Immunohistochemistry
Cultured lungs were preserved after 78 hours in 4% paraformaldehyde(0.1
M phosphate-buffered saline [PBS], pH 7.4), rinsed in PBS, cryoprotected
with 20% (w/v) sucrose, gelatine-embedded (7.5% [w/v] gelatin, 15%
[w/v] sucrose in PBS) before being covered in Cryo-M-Bed (Bright,
Huntingdon, UK) and snap-frozen at -40°C. Lung sections were taken at
7um and mounted on chromealum gel slides for storage at -40°C.
Slides were rinsed in PBS and incubated with a-smooth actin antibody
(monoclonal anti- a-SMA Clone No.1A4, mouse; Sigma, Gillingham, UK)
at 1:500 dilution with 0.1% BSA in PBS overnight at 4°C. They were then
rinsed in PBS andthe primary antibody labelled with FITC-labelled goat
anti-mouse IgG (Sigma, Gillingham, UK) at 1:100 dilution. Slides were
then mounted with fluorescent mounting medium (S3023; Dako, Ely, UK).
3.2.7 Statistical analysis
Data processing was performed using Origin 6.0 software (OriginLab
Corporation, Northampton, MA, USA). The SPSS v12.0 package (SPSS
UK Ltd., Woking, UK) wasutilised for statistical analysis. Parametric data
are reported as mean + SEM and compared using Student’s t-test. Non-
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parametric data are reported as medians (interquartile ranges) and
compared with Mann Whitney test. Statistical significance was taken at
p < 0.05.
3.3 Results
3.3.1 Spontaneous Ca”*; waves propagate via smooth muscle
cells prior to contraction
Confocal imaging of Fluo-4 loaded embryonic lungs (n = 16) with low
power magnification (4x or 10x) at 37°C, revealed intercellular Ca”*; waves
propagating longitudinally through principal airways (Figure 3.1A). The
propagating Ca*"; waves originated from the trachea (Region 1, red box;
Figures 3.1A, B, and D) or the second bronchial division of the right lung
rudiment (Region 2, black box; Figures 3.1A, C, and D). Infrequently
separate intercellular Ca”*; waves emanated simultaneously from two foci
(data not shown). Theinitial phase of the Ca’’; transient differed between
sites of Ca’'; wave initiation and sites of propagation (Figure 3.1D).
Irrespective of the site of origin and direction of travel, Ca’*, waves
propagated with an average speed of 219 + 14 um/s (n = 4 lung explants,
10 individual Ca**; waves), andafter a short delay (349 + 30 ms, n= 4 lung
explants), were followed by the mechanical contractile wave (recorded as
the decrease in the airway luminal diameter)(Figure 3.2). Contractile ASM
wavesinvariably propagated from the Ca”*; waveorigin at a similar speed:
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Figure 3.1. Intercellular Ca"; waves in embryonic lungASM. (A)
Transmitted light photomicrograph of a whole lung explant after 54 h
in vitro: the dashed box contains the proximal airways shown in B and
C (T = Trachea; R = Right and L = Left lung rudiments; Marked
regions 1 and 2 are thesites of recording of the Ca’’; transients in D).
(B and C) Stacks of pseudo-color confocal images of Fluo-4—loaded
airways showing propagating Ca*’; waves with the initiation site
(marked byan asterisk) in the trachea (B) and right lung rudiment(C).
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Figure3.1. Intercellular Ca”*; waves in embryonic lung ASM.(D) Ca’’;
transients measured in regions | and 2 (see A). The Ca"; wave
originates in the trachea (region 1; fop) or the right lung (region 2;
bottom). (E) Left-hand panel shows immunohistochemistry for o -
smooth actin on a 7-um section of a cultured lung explant. Smooth
muscle cells expressing a-smooth actin are arranged perpendicular to
the long axis of the airway (T = Trachea; R = Right and L = Left lung
rudiments). Right-hand panel showsgreyscale image of Fluo-4—loaded
individual smooth muscle cells (outlined by dashed line) surrounding
embryonic airway at 60x objective magnification. The arrow
demonstrates the long axis of the airway. Marked regions i (black) and
ii (red) are the sites of recording of the Ca**; transients in F. (F) Ca’’;
transients recorded in areas 1 and 2 (marked oncells at 60x objective
magnification in £).
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Figure 3.2. Relationship between Ca”’; waves and ASM mechanical
contractility. (A) Transmitted light image of a cultured lung (the
dashed box contains the region shown at high magnification in B). T
= Trachea; R = Right and L = Left lung rudiments. (B) Stack of
grayscale transmitted light images showing airway contractility. The
dashed arrow gives the direction of the contractile wave. The small
arrows demonstrate the airway lumen.
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Figure 3.2. Relationship between Ca’*; waves and ASM mechanical
contractility. (C) Change in Ca**; as shown by F/Fp (top) and lumen
diameter in um (bottom) with time. Fluorescence was measured at
510 nm andis expressed as a function ofmaximum comparedto basal
values (F/Fo).
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177 + 32 um/s (n = 4 lungs, 8 contractile waves). Using high power
magnification (60x objective), Ca°*; waves were also recorded in
individual smooth muscle cells (Figure 3.1E, F). Ca’’; transients recorded
photometrically or confocally exhibited similar time courses and 4 distinct
phases(i) fast upstroke, (ii) slow attainment of peak, (iii) plateau and (iv)
relaxation (Figures 3.3A and 3B). Using a 60x objective, developing ASM
cells were observed lying circumferentially around the developing airway
with their long axes perpendicular to that of the bronchi (Figure 3.1E). The
diameters of these cells were approximately 8-14 um. Histology and a-
actin immunohistochemistry (n = 10) confirmed this typical ASM
orientation (Figure 3.1E) (Sparrow ef al. 2003).
3.3.2 Role of gap junctions
The propagation speed (Yamazawa ef al. 2002; Stevens et al. 1999;
Hashitani et al. 2001) and temporal phases (Burdygaef al. 2002) (above)
of ASM intercellular Ca"; waves are consistent with an action potential-
mediated mechanism. Propagation of the action potential in smooth muscle
tissue is mediated by gap junctions (Hashitani ef al. 2001; Hashitanief al.
2004), To test whether propagating Ca’*; wavesin the present experiments
required gap junction integrity, we studied the effects of the gap junction
uncoupler 18-8 glycyrrhetinic acid (40 1M) on the Ca’*; waves. 18-B
glycyrrhetinic acid abolished both propagating Ca**; waves and
coordinatedperistalsis after an initial brief excitatory phase (n = 4)(Figure
89
1.15
P/F  tool
Figure 3.3. Effects of gap junction blockade and cooling on lung
Ca*'; oscillations. (4) Transmitted light image of the proximal
airways of an embryonic lung. The dashed box shows the region
where Ca”"; transients were recorded. (B) Superimposed normalized
traces of a typical Ca”*; transient recorded photometrically (black
trace) and confocally (red trace) from the region in A. Fluorescence
was measured at 510 nm andis expressed as a function ofmaximum
comparedto basal values (F/Fo).
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Figure 3.3. Effects of gap junction blockade and cooling on lung Ca’*;
oscillations. (C) Inhibition of Ca*"; oscillations by 18-8-glycyrrhetinic
acid (40 1M). (D) Airway Ca’’; oscillations at 37°C and 27°C. The
ratio of the fluorescence signal (F400/500) was used as an indicator of
2+Ca iv
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3.3C).
3.3.3 Effects of moderate cooling
Airway peristalsis and excitation-contraction coupling are temperature
dependent (Lewis 1924; Burdygaet al. 2002). We therefore compared the
temporal characteristics and frequency ofASM Ca’’; transients at 37°C and
27°C. Amplitude of the spontaneous Ca*"’; transients is conventionally
expressed as a percentage of peaks obtained with depolarising 120mM K*
solution or 100 uM carbachol. Amplitude of spontaneous Ca’*; transients
(% of high K* peak) was 27 + 2% (n = 17 lungs) at 37°C and 22 + 2% (n=
11 lungs) at 27°C (p = NS).In contrast, as a percentage of carbachol peak,
amplitude of spontaneous Ca**; transients was 28 + 4% (n = 5 lungs) at
37°C and 15 + 2% (n= lungs) at 27°C (p = 0.01). Cooling to 27°C had no
effect on time to 50% of peak amplitude of the Ca’’; transient whilst
plateau phase, relaxation half-time (Tso) and duration at 50% amplitude
were significantly prolonged (Table 3.1). There was a trend toward higher
frequency Ca’'; oscillations at 37°C (0.81 + 0.06 per minute, n = 23)
compared to 27°C (0.7 + 0.06 per minute, n = 22). Figure 3.3D highlights
this trend.
3.3.4 Effects of Ca”* and K* channel modulators
‘Zero Ca’”’ solution (with 2 mM EGTA) decreased baseline Ca**; and
rapidly abolished both Ca*"; transients andperistalsis (n=4)(Figure 3.4A).
92
37?C(n=5) 27°C (n=5) Pp
 
values
Fast phase duration (s) 0.68 + 0.05 0.92 + 0.08 0.027
Fast phase amplitude (% of  73.0641.49 75.83 £2.33 NS
peak) 0.45 + 0.03 0.57 + 0.06 NS
Time to 50% amplitude (s)
Slow phaseduration (s) 1.06 + 0.12 1.18 £0.17 NS
Plateau duration (s) 1.94 40.15 3.32 £0.27 0.002
Relaxation half time, Tso (s) 2.76 £ 0.44 4.57 = 0.33 0.01
Width at 50% amplitude (s) 5.99 + 0.56 9.44 + 0.54 0.002
TABLE 3.1. Temporal characteristics of Ca*"; oscillations recorded at
37°C and 27°C
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Readmission of Ca** quickly restored Ca’’; oscillations and mechanical
activity. These data indicate that Ca”", entry is required for the generation
of propagating Ca’; waves. Blockade of L-type Ca** channels with
nifedipine (10 4M) rapidly abolished spontaneous Ca’’; transients and
peristalsis whilst reducing baseline Ca’*; (n = 4)(Figure 3.4B). In contrast,
the L-type Ca”* channel agonist, Bay-K 8644 (1 1M; n = 4)raised Ca”,
increased Ca**; wave amplitude (from 27 + 5% to 46 + 5% of peak
obtained with depolarising 120mM K"solution; p = 0.045) and frequency
(from 0.53 + 0.14 to 2.57 + 0.61 per minute; p = 0.017)(Figure 3.4C). The
K* channel blocker TEA (10 mM; n = 4) produced a trend toward
increased Ca”*; wave amplitude (from 13 + 4% to 23 + 7% of peak with
high K* solution; p = NS) and frequency (from 0.65 + 0.23 to 1.63 + 0.46
per minute; p = NS)(Figure 3.4D). These data suggest that amplitude,
duration and frequency of the Ca’’; transients are controlled by L-type Ca’*
channels and potentially by TEA-sensitive K* channels (voltage gated (Ky)
or large conductance (BK) channels or both).
3.3.5 Role of the sarcoplasmic reticulum
Ca** handling by the sarcoplasmic reticulum is vital in smooth muscle
excitation-contraction coupling. Ca"; release is mediated by SR channels,
ryanodine receptors (RyR) and inositol triphosphate receptors (InsP3R);
removal of released Ca’*; from the cytoplasm occurs primarily via the SR
Ca**-ATPase (SERCA pump)(Sanders 2001; Taylor et al. 2002).
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Figure 3.4. Effects of Ca”* channel and K* channel modulators on
Ca*'; oscillations in embryonic lung ASM.(A) Reversible inhibition
of Ca’*; oscillations by removalof external Ca’* (0 Ca’* solution with
2 mM EGTA). (B) Abolition of Ca’*; oscillations by L-type Ca™*
channel blocker (nifedipine (10 pM). (C) Increased frequency of
Ca’*; oscillations with L-type Ca’* channel agonist Bay-K 8644 (1uM). (D) K* channel blocker (TEA, 10 mM) increases Ca”;
oscillation frequency. The Y-axis shows the Indo-1 ratio (F4oo/soo)
which was usedas an indicator of Ca”*,.
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Caffeine facilitates Ca”*; -induced Ca”* release (CICR) properties of RyR
(Endo 1977). Carbachol activates InsP3R-mediated SR Ca*’; release
through inositol triphosphate (IP3) production (Sanders 2001; Tayloret al.
2002). Their effects were studied after initial application of high K*
solution (to generate a 100% reference for Ca’’;) and then, to eliminate
plasmalemmal Ca”* entry, 2 minutes superfusion with Ca’’-free solution
(which decreased Ca”")). Application of 20 mM caffeine then transiently
increased Ca”*; (15% + 7% of high K" response; n = 4)(Figure 3.5A) with
brief tonic airway contraction. Subsequent application of carbachol (100
uM)for 1 minute generated high amplitude Ca’’; transients (120 + 27% of
high K* response; n = 4)(Figure 3.5A) and sustained tonic contraction.
Therefore embryonic ASM cells appear to possess a sarcoplasmic Ca’’;
store that is releasable via both RyR and InsP3R channels.
To examinethe role of the SR in regulation of Ca"; waves in embryonic
airway smooth muscle westudied the effects on the Ca’’; transients of (a)
blocking the SERCA pump with CPA (Kosterin e¢ al. 1996), (b) activating
CICR via RyRs with caffeine (Endo 1977), (c) blocking RyR channels
with ryanodine (Fill et al. 2002) or (d) blocking InsP3Rs with 2-APB
(Maruyamaet al. 1997).
CPA (20uM) (n = 4) markedly increased baseline cytosolic Ca”"; and
gradually abolished Ca**; transients (Figure 3.5B). Similarly phasic
mechanical contractions were progressively replaced by tonic airway
contraction. Removal ofCPA from the bathing solution reversedits
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Figure 3.5. Sarcoplasmic calcium regulates Ca’’; oscillations in
embryonic ASM.(A) Agonist-induced SR Ca** release: Ca**; recording
showing the effects of high K*, caffeine (20 mM), and carbachol (100
uM). Caffeine and carbachol were applied after 2 min exposure to a 0
Ca** solution. Abolition of Ca’’; oscillations by (B) CPA (20 1M), (C)
caffeine (1 mM), (D) 2-APB (50 uM), and (£) Ryanodine (20 uM). The
Y-axis shows either the Fura-2 ratio (F3493g0) or Indo-1 ratio (F4oo/soo)
which was used as an indicator of Ca’",.
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effects. Caffeine’s effects on Ca”", were dose-dependent: caffeine (1 mM)
initially stimulated and then abolished Ca**; waves and contractility (n =
4)(Figure 3.5C). Caffeine (10 mM) increased baseline Ca”*; and basal tone
with abolition of Ca’*; waves (n = 4) (data not shown). Variation in
caffeine’s effects may be due to complex sequelae of CICR that may
include activation of depolarizing chloride channels and / or
hyperpolarizing K* channels (Wellman et al. 2003; Kotlikoff et al. 1998).
Blockade of the latter by TEA (10 mM) prevented caffeine’s action and
suggests that caffeine-induced CICR does mediate K* channel opening (n
= 4; data not shown). Ryanodine (20 1M) also abolished spontaneous Ca”";
waves and contractility (n = 4) (Figure 3.5E). InsP3R blockade by 20-
minute application of 2-aminoethoxy-diphenylborate (2-APB; 50 1M)
increased baseline Ca”*; and gradually abolished both Ca’; waves and
contractility (n = 4) (Figure 3.5D) (Bilmen ef al. 2002; Missiaen et al.
2001). Collectively these data demonstrate that sarcoplasmic calcium
uptake via the SERCA pumpand release via RyR and InsP3R channels are
required for spontaneous propagating ASM Ca’’; waves and consequent
peristalsis.
3.4 Discussion
Postnatal ASM function is under study due to its contribution to the
morbidity of asthma. Now prenatal ASM activity is subject to increasing
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scrutiny because of accumulating evidence that prenatal airway peristalsis
(AP) regulates early lung growth (Jesudason ef al. 2005). Altering either
AP frequency or lung growth yields parallel changes in the other
(Jesudasonet al. 2005). Taking a specific example, nifedipine (L-type Ca”*
antagonist) not only abolishes AP (McCray 1993; Sparrow et al. 1994) but
also inhibits lung morphogenesis and pulmonary cell proliferation in vitro
(Roman 1995; Jesudason et al. 2005). Moreover, transgenic pulmonary
epithelial expression of an inhibitor ofthe Ca”*-binding protein calmodulin
disrupts lung morphogenesis in vivo (Wang et al. 1996). Given these
observations, we postulated that Ca”; signalling represents a promising
mechanistic link between AP and lung growth.
3.4.1 Novelin-situ measurementof Ca”*; in whole lung explants
Wereport the first demonstration of prenatal pulmonary Ca’’; waves,
determination of their spatiotemporal characteristics, and their
relationship to consequent peristaltic airway contraction. We achieved
this technically exacting task by Ca’*-sensitive indicator loading of whole
embryonic lung (rather than single cell preparations). Given that AP
involves the entire airway, whole organ Ca’; imaging has been
invaluable. We examined Ca’; waves with confocal imaging to measure
spatiotemporal propagation, and photometric techniques for extended
measurements and pharmacologic manipulation. Finding both techniques
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yielded similar Ca’; wave morphology reinforces the validity of our
approach.
3.4.2 Airway peristalsis is underpinned by spontaneous Ca”*;
waves
Using high-power magnification, we provide the first evidence that
prenatal pulmonary Ca’; waves propagate through typically arranged ASM
cells rather than epithelium. Our data show that Ca”*; wavesare transmitted
via cells whose longitudinal axis is perpendicular to the airway.
Furthermore the recordings demonstrate that these samecells then rapidly
and invariably contract. Smooth muscle «-actin immunohistochemistry
confirms that these cells are arranged in a typical circular fashion around
the airway and are indeed ASM (Sparrow et al. 2003). Together this
strongly indicates that ASM Ca”*; wave propagation causes AP.propag,
3.4.3 Ca”*; waves are probably action potential-mediated
Calcium-dependent action potentials have been documented in a wide
variety of smooth muscle (Duthie 1974; Weiss et al. 2006; Young 2007;
Huizinga et al. 2009). Their unequivocal demonstration requires micro-
electrode recording. However, small preparations such as embryonic lung
present considerable difficulties: contractile activity readily dislodges
micro-electrodes. Addressing this problem by pharmacologic abolition of
contractility may simultaneously extinguish Ca’*; waves. Instead, we can
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contend that ASM Ca"; wavesare likely to be action potential—-mediated
after demonstrating their following typical features: (/) high wave speed
(Yamazawaet al. 2002; Stevens et al. 1999; Hashitani et al. 2001), (2)
capacity for multidirectional propagation, (3) characteristic four-phase
morphology of transients (Burdyga et al. 2002), (4) gap junction—
dependent propagation (Hashitani ef al. 2001; Hashitani et al. 2004), and
(5) apparent regulation by membrane potential. Observations that support
the latter point include: delaying repolarization with 10 mM TEAincreases
Ca”*; wave frequency and amplitude; depolarization with high-K* solution
entrains a Ca’*; wave andcontractility (data not shown); voltage-gated Ca**
channelactivity is required for and regulates ASM Ca”*; waves.
3.4.4 Ca”*; wave generation requires extracellular calcium entry
Wehavealso demonstrated key mechanisms for generation and regulation
of spontaneous ASM Ca”"; waves. Initially, we compared the temporal
characteristics of ASM Ca**; transients at 37°C and 27°C. Consistent with
passive influx of Ca”*,, temperature reduction affected neither the early
sharp rise in Ca’’; nor response to high K* (Burdyga ef al. 2002). In
contrast, plateau phase, Ts) and duration at 50% amplitude were
significantly prolonged, consistent with a requirement for active removal of
cytosolic Ca** (Burdyga et al. 2002). These data implicate a plurality of
Ca’* transport processes in the generation of airway Ca”*transients.
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Weestablished that Ca’, entry via L-type channels is necessary for, and
regulates, spontaneous regenerative ASM Ca’, waves. Ca"; waves were
abolished by removal, and then reinstated by reintroduction of external
Ca’*. Abolition of AP by nifedipine was accompanied by cessation of
periodic Ca”’; oscillations. The L-type Ca’* channel agonist Bay-K 8644
increased Ca”; wave frequency and baseline Ca”‘;, whereas ‘zero Ca?”
solution or nifedipine preventedthis.
3.4.5 Ca”; wave generation requires intracellular calcium
release
However, Ca’", influx aloneis insufficient for generation of ASM Ca”’;
waves: Ca”* uptake/release from the sarcoplasmicreticulum is required for,
and regulates, ASM Ca’; waves. Thus, cyclopiazonic acid, which empties
the SR (Kosterin et al. 1996), abolished spontaneous Ca’*; waves and
peristaltic activity while increasing basal tone. Similar effects have been
reported in gravid rat myometria (Taggart ef al. 1998). Second, inhibiting
SR Ca’* release via RyR channels, or InsP3R channels abolished Ca”*;
wave generation and peristalsis (Hashitani et al. 2004; Liu et al. 2005a; Liu
et al. 2005b). Third, we observed initial stimulation and subsequent
abolition of Ca*’; waves when facilitating Ca?*-induced Ca"; release with
caffeine. This biphasic response may result from activation of not only
depolarizing Ca’*-activated chloride channels (with positive feedback and
increased contractile frequency), but also large-conductance (BK) Ca”*-
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activated K* channels (which produce hyperpolarization and cessation of
periodic mechanicalactivity) (Wellman et al. 2003; Kotlikoff et al. 1998).
Because TEA blockade of Ky and BK channels prevented the effects of 1
mM caffeine, the latter mechanism is suggested.
3.4.6 Ca”*; waves maydrive lung development
In this first study to demonstrate prenatal pulmonary Ca’’; oscillations, we
have provided clear evidence that peristaltic contractions of the prenatal
airway are produced by spontaneous, regenerative, temperature-dependent
Ca’; oscillations of myogenicorigin that require Ca’",influx, sarcoplasmic
Ca’* uptake, Ca’’; release via RyR and InsP3R channels, and propagate via
ASMcells in a gap junction—dependent mannerthat is likely to be action
potential—-mediated. Two striking consequences of these novel findings
deserve immediate discussion.First, if as recent data suggest, AP regulates
prenatal lung growth (Jesudasonef al. 2005), then from the present study
we can assert that intercellular Ca**, oscillations in turn regulate antenatal
lung development. Ca” signalling certainly participates in diverse roles
ranging from transcriptional regulation and cell cycle kinetics (Berridge
1997) to modulation of cellular tension and contractility. Based on the
present findings, we now propose that propagation of intercellular Ca";
oscillations throughout a complex developing organ maybe integral to, and
help coordinate, morphogenesis.
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Second, our demonstration of regular spontaneous Ca*’; waves and phasic
contractility in embryonic ASM contrasts sharply with infrequent
spontaneous Ca’*; oscillations and tonic contractility in adult ASM (Boyle
et al. 1992; Bergneret al. 2002). The stimulusfor transition between ASM
phenotypes is unknown. Indeed, although birth may be assumed to mark
the phenotypic change, this has not been unequivocally demonstrated.
ASMphenotype maybe transformed by the same influences that modulate
uterine contractility at the onset of labour (Shmygol et al. 2007; Young
2007; Wray ef al. 2008). Alternatively descending neural control may
change ASM behaviour: while AP persists beyond structural development
of the pulmonary nervous system, our studies show how muscarinic
activation and InsP3R-mediated Ca”* release could induce tonic
contractility. Perhaps muscarinic activation of InsP3R-mediated Ca’’;
release is incomplete prenatally. Developmental maturation of this pathway
might then explain the transition between ASM phenotypes.Clearly further
investigation of both pre- and postnatal ASM will be required to test these
possibilities.
3.5 Conclusions
a) Prenatal airway peristalsis is driven by temperature-sensitive
. . 2+ : :spontaneous regenerative myogenic Ca’; oscillations.
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b) Ca’’, waves propagate between individual airway smooth muscle
cells coupled via gap junctions.
c) Ca’*; wavesare likely to be action potential—mediated (high wave
speed, capacity for multidirectional propagation, characteristic
four-phase morphology, gap junction-dependent propagation and
apparent regulation by membrane potential).
d) Ca’*,; waves are dependent on not only Ca’*, entry via L-type
voltage-gated channels but also dependent on Ca’; stores.
e) If AP regulates lung growth, these findings suggest that ASM Ca”*;
waves mayin turn regulate prenatal lung morphogenesis.
f) Future studies are directed to exploring the relationship of Ca’*;
oscillations to lung growth and understanding the differences
between pre- and postnatal ASMactivity.
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Chapter 4
AIRWAY SMOOTH MUSCLE DYSFUNCTION
PRECEDES TERATOGENIC CONGENITAL
DIAPHRAGMATIC HERNIA AND MAY
CONTRIBUTE TO HYPOPLASTIC LUNG
MORPHOGENESIS
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4.1 Introduction
Fetal interventions are undertrial to improve hypoplastic lung function and
growth in CDH (Harrison et al. 2003; Deprest et al. 2005). Despite
promising experimental and preliminary clinical data, conclusive evidence
to back these interventions is awaited. To optimize such prenatal therapy, a
better understanding of the determinants of lung growth is required
(Warburton ef al. 2000).
Normal lung growth is governed by a combination of biochemical and
mechanical factors (Hogan 1999; Harding et al. 1996). For example,
fibroblast growth factor-10 (FGF10) is required for branching
morphogenesis and proximodistal pulmonary differentiation, whilst fetal
breathing movements, lung liquid-induced stretch and ASM peristalsis
appear to modulate pulmonary growth (Harding ef al. 1996; Jesudason ef
al. 2005; Shannonet al. 2004; Bellusci et al. 1997). Evidence that FGF-10
is produced by ASM progenitors provides a putative link between
biochemical and mechanical stimuli to lung growth and underlines the
importance of ASM in lung development (Mailleux et al. 2005). ASM
undergoes spontaneousperistaltic contractions prenatally in a variety of
species including humans (McCray 1993; Schittny et al. 2000). This
activity is coupled to, and appears to regulate, normal lung growth
(Jesudason et al. 2005); these peristaltic waves are underpinned by
temperature sensitive, gap-junction dependent propagating ASM Ca’’;
waves(Featherstoneet al. 2005). Notably, transgenic pulmonary epithelial
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expression of an inhibitor of the Ca’*-binding protein, calmodulin, disrupts
lung morphogenesis in vivo (Wang et al. 1996). If ASM function is
important to normal lung growth, one might expect evidence of ASM
abnormalities when lung growth is defective. Indeed, in both human and
experimental lung hypoplasia ASM-related dysfunction is apparent near
term. Human hypoplastic lung exhibits abnormalities of serum response
factor (SRF) isoforms (SRFs regulate ASM gene expression) (Yangefal.
2000). In the nitrofen model of CDH, ASM hypercontractility is apparent
near term (Belik ef al. 2003). Moreover, survivors of CDH suffer with
long-term bronchial hyperreactivity (Boas et al. 1996).
Wehave hypothesized that rather than being the ‘appendix of the lung’
(Mitzner 2004), ASM helps regulate early lung morphogenesis, e.g., via its
interrelationship with FGF-10 production, and also modulates later fetal
lung growth, via effects on lung compliance. Certainly when normal
neonatal lung is exposed experimentally to chronic positive pressure
ventilation, ASM dysfunction (airway hyper-reactivity) emerges in tandem
with significant airway remodelling, again linking ASM activity and
morphogenesis (Jobe et al. 2001). If, therefore ASM plays a key role in
regulation of fetal lung compliance and hence growth, it seemslikely that
abnormal ASM function in hypoplastic fetal lung may not only impairlate
prenatal growth, but also increase susceptibility to postnatal barotrauma
and remodeling.
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In the present study we have tested the hypothesis that near term ASM
dysfunction seen in hypoplastic CDH lunghas its origins not simply in
compression ofthe fetal lung by a visceral hernia, but is apparent from the
embryonic stages of hypoplastic lung development (Jesudason 2006;
Jesudasonet al. 2006).
Wehave used Ca’’; imaging of hypoplastic lung primordia to demonstrate
early ASM dysfunction: Ca’; transients in hypoplastic lung feature
prolonged plateau phase, reduced frequency (at certain temperatures) and
increased amplitude. Given that we have also shown that hypoplastic lung
ASM Ca", transients have normal dependence on Ca"; and Ca", and gap-
junction mediated propagation, the anomalous temporal characteristics of
these Ca”’; transients suggest a key problem in the ASM ion channels/
action potential generation.
4.2 Materials and methods
4.2.1 Generation of experimental lung hypoplasia and controls
Nitrofen (2,4-dichloro-4’-nitrodiphenylether) 100mg (Zheijang
Chemicals, Hangzhou, China) dissolved in olive oil was gavage fed to
timed-pregnant Sprague-Dawley rats (Charles River Ltd, Margate, UK) on
day 9.5 of gestation (vaginal plug = day 0, term = day 22.5) to induce
embryonic lung hypoplasia by day 13.5 of gestation and left-sided CDH
and pulmonary hypoplasia in newborn pups (Kluthef al. 1990).
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4.2.2 Retrieval of embryonic lung primordia
See section 3.2.1.
4.2.3 Embryonic lung culture
See section 3.2.1
4.2.4 Assessmentofviability
See section 3.2.2
4.2.5 Loading lung explants with Ca”‘; sensitive fluophores
See section 3.2.3
4.2.6 Confocal and photometric measurements
See section 3.2.4
4.2.7 Solutions
Unless otherwise stated, lung explants were superfused at 37°C with
buffered physiological saline (pH 7.4) containing (mM): 120 NaCl, 5.6
KCl, 0.12 MgSO4, 2 CaCh, 11.7 glucose, 10.9 HEPES. ‘Zero Ca‘*
solution used in certain experiments consists of physiological saline with
CaCl, omitted and 2 mM EGTA added. Other additions to standard
superfusate that were investigated include: the L-type Ca’* channel
antagonist, nifedipine (10 1M); the L-type Ca** channel agonist, Bay-K
8644 (1 1M); the gap junction uncoupler, 18-8 glycyrrhetinic acid (18-
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BGA, 40 uM); the K* channel antagonist, tetraethylammonium (TEA, 10
mM); the sarcoplasmic reticulum (SR) Ca”*ATPase inhibitor,
cyclopiazonic acid (CPA, 20 uM); caffeine (1 mM - 20 mM),to facilitate
calcium induced calcium release (CICR) via ryanodine receptors (RyR);
ryanodine (20 uM), to inhibit ryanodine receptors; the muscarinic agonist,
carbachol (1 uM - 100 uM); 2-aminoethoxy-diphenylborate (2-APB, 50
uM), a putative inhibitor of inositol triphosphate channels (InsP3R); and
depolarising high K° solution (10 mM - 140 mM). Carbachol and
ryanodine were dissolved in distilled water; CPA, 2-APB and 18-BGA
were dissolved in dimethylsulfoxide (DMSO), whilst nifedipine and Bay-K
8644 were dissolved in ethanol (EtOH). Ca’*; wave generation and airway
contractility were unaffected by applications of vehicle alone (DMSO or
ETOH). Ryanodine was obtained from Calbiochem (Merck Biosciences
Ltd., Nottingham, UK). Sigma (Poole, Dorset, UK) supplied all other
chemicals.
4.2.8 Immunohistochemistry
See section 3.2.6
4.2.9 Statistical analysis
Data processing was performed using Origin 6.0 software (OriginLab
Corporation, Northampton, MA, USA). The SPSS v12.0 package (SPSS
UK Ltd., Woking, UK) was utilised for statistical analysis. Parametric data
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are reported as mean + SEM and compared using Student’s t-test. Non-
parametric data are reported as medians (interquartile ranges) and
compared with Mann Whitney test. Statistical significance was taken at
p < 0.05. Dose response curves were created using Origin Microcal
sigmoidalfitting to the experimental points presented as means + SEM.
4.3 Results
4.3.1 Temporal characteristics of ASM Ca”; waves are
abnormalin experimental lung hypoplasia
Hypoplastic lung primordia exhibited spontaneous regenerative
intercellular Ca", waves similar to those previously demonstrated in
control embryonic lungs (Featherstone et al. 2005). Confocal imaging of
Fluo-4 loaded hypoplastic lungs with low power magnification (4x or 10x)
at 37°C, revealed intercellular Ca’*; waves propagating longitudinally
through the principal airways. Similar to control lungs (Featherstoneet al.
2005), hypoplastic ASM Ca’*; waves initiated from regions within the
trachea, the left or right main airway, or occasionally from two foci
simultaneously. High power magnification (60x) revealed the Ca’**; waves
propagated via individual ASM cells, rather than undifferentiated
mesenchymeorairway epithelium. Developing ASM cells were identified
by their characteristic spindle-shape, immediate sub-epithelial location, the
orientation of the cell’s long axis perpendicular to the adjacent airway long
axis and their smooth muscle actin immunopositivity (data not shown) as
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previously described (Featherstone ef al. 2005). Hypoplastic lung
intercellular Ca’*; waves propagated with an average speed of 241 + 14
um/s (n=4, 24 individual Ca”*; waves); a similar speed to Ca”*; wavesin
control lung (219 + 14 um/s; n=4, 10 individual Ca”"; waves) (p = NS).
Despite these similarities, the temporal characteristics of hypoplastic lung
ASM Ca’'; transients were altered compared to control ASM Ca’*,
transients at both 37°C and 27°C (Figure 4.1). Hypoplastic lung ASM Ca”";
transients show characteristic 4-phase morphology: (1) fast phase; (2) slow
phase to plateau; (3) plateau phase and (4) relaxation phase. Hypoplastic
lungs had an elongation of the plateau phase alone compared to normal
control lung (2.45 + 0.13 sec vs. 1.94 + 0.15 sec, p = 0.028); this
prolongation was accentuated by cooling to 27°C (4.83 + 0.29 sec vs. 3.32
+ 0.27 sec, p = 0.005) (Table 4.1) and accompanied by a significant
reduction in the frequency of Ca’’; oscillations (0.49 + 0.04 vs. 0.7 + 0.06
per minute, p = 0.003) (Table 4.1). The frequency of Ca’*; oscillations at
37°C did not differ significantly between hypoplastic and normal lungs
(0.67 + 0.06 vs. 0.81 + 0.06 per minute, p = NS) (Figure 4.1).
4.3.2 Hypoplastic lung ASM Ca”*| transients require Ca”*, entry,
Ca*, release and gap junction mediated propagation
Normal ASM Ca”"; transients in control lung require (i) extracellular Ca’*
(Ca’*,) entry, (ii) intracellular Ca** (Ca”*\) release from the sarcoplasmic
(SR) and(iii) propagation (at a speed characteristic of an action potential-
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Figure 4.1. Ca", transients within hypoplastic lung primordia have
altered temporal characteristics. Superimposed normalized traces of
typical Ca’’; transients recorded photometrically at 37°C and 27°C in
nitrofen hypoplastic lungs (red traces) and control lungs (black traces).
Intracellular Ca’* (Ca”*;)is shown onthe y-axis (arbitrary units).
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37°C 27°C
Nitrofen Control p value Nitrofen Control p value
(n=9) (n=5) (n= 8) (n=5)
Fast phase 0.55+0.08 0.68+0.05 NS 1.07+0.16 0.92+0.08 NS
duration (s)
Time to 0.38+0.05 0.45+0.03 NS 0.75+0.12 0.57+0.06 NS
50%
amplitude
(s)
Slow phase 1.00+0.12 1.06+0.12 NS 1.62+0.20 1.18+0.17 NS
duration(s)
Plateau 2.45+0.13 1.94+0.15 0.028 4.834029 3.32+0.27 0.005
duration (s)
Relaxation 2.77+0.31 2.76+0.44 NS 4.52 £0.38 4.57+0.33 NS
half time,
Tso (s)
Width at 6.194033 5.99+0.56 NS 1131+ 9.44 + 0.54 NS
50% 0.79
amplitude
(s)
37°C 27°C
Nitrofen Control p value Nitrofen Control p value
(n= 26) (n= 23) (n = 28) (n= 22)
Frequency 0.67 + 0.81 +4 NS 0.49 + 0.7 + 0.06 0.003
per minute 0.06 0.06 0.04
Table 4.1. Ca’’; transients within hypoplastic lung primordia|have altered
temporal charactetistics. (B) Temporal characteristics of Ca’*; transients
 
recorded at 37°C and 27°C in hypoplastic and control lung. primordia.
Data are presented as mean + SEM.(C) Frequency of Ca’; transients
recorded at 37°C and 27°C in hypoplastic and control lung primordia.
Data are presented as mean + SEM.
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potential-mediated event) via gap junctions (Featherstone et al. 2005).
Given the observed differences in the temporal characteristics of
hypoplastic ASM Ca’*; oscillations, we tested whether hypoplastic lung
ASMhaddifferent requirements for Ca**, entry (using ‘zero Ca*”’ solution,
nifedipine, Bay-K 8644 and TEA), Ca’’; release (using caffeine, carbachol,
CPA, TEA, ryanodine and 2-APB) and / or gap junction mediated
transmission (using 18-B-GA).
There were no gross differences between hypoplastic and normal lungs in
the requirements ofthese three elements of Ca”” signaling for the initiation
or regulation of Ca’*; oscillations (Figures 4.2 and 4.3). Thus, in
hypoplastic lung, propagating ASM Ca’’; transients (and consequent
peristaltic contraction) require (i) external entry of Ca’* via L-type Cc
channels, (ii) sarcoplasmic reticulum (SR) Ca** uptake via the SR
Ca**ATPase (SERCA pump),(iii) Ca** release via ryanodine (RyR) and
inositol triphosphate (InsP3R) channels and (iv) functioning gap junctions.
4.3.3. Relative amplitudes of ASM Ca”; transients in
hypoplastic lungs are increased
Observed differences in the morphology and frequency of hypoplastic lung
ASM Ca’";transients are not readily attributable to abnormality of extra- or
intracellular Ca”* signalling examined thus far. To further elucidate the
observed abnormality of ASM Ca’’; transients in lung hypoplasia, the
amplitudes of spontaneous Ca’"; transients were analysed in normal and
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Figure 4.2. Ca; transients,Within hypoplastic lung primordia are
dependent on extracellular Ca’ and gap junction integrity.A) Exposure
of lungs to a Ca’‘free solution decreased baseline Ca”*; and rapidly
abolished both Ca’*; transients and peristalsis in hypoplastic lung
explants. Readmission of Ca** quickly restored Ca”; oscillations and
mechanical activity. (B) Nifedipine (L-type Ca** channel blocker)
rapidly abolished spontaneous Ca’’; transients andPeristalsis whilst
reducing baseline Ca’. (C) Bay-K 8644 (L-type Ca’** channel agonist)
raised Ca’";, increased Ca’’; waveamplitude and frequency. (D) TEA
(K* channel blocker) increased Ca"; wave amplitude and frequency (E)
The gap junction uncoupler 18-B-glycyrrhetinic acid abolished both
propagating Ca*’; waves andcoordinatedperistalsis after an initial brief
excitatory phase. Data were obtained at 27°C.
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Figure 4.3. Sarcoplasmic Ca** regulates Ca’’; oscillations in embryonic
hypoplastic ASM (A) Caffeine was used to facilitate the Ca’*-induced Ca”*
release (CICR) properties of RyR & carbachol wasused to activate InsP3R-
mediated SR Ca’release via inositol| triphosphate (IP3) production. Ca’"-
free solution was used to eliminate Ca”", entry. Caffeine (20 mM)transiently
increased Ca’‘;, accompanied by brief tonic airway contraction. Carbachol
(100 uM) generated high amplitude Ca’*, transients and sustained tonic
contraction. (B) SERCA pump blockade with CPA markedly increased
baseline Ca’*; and abolished Ca’; transients. Phasic mechanical contractions
were replaced by tonic airway contraction. (C) Facilitating CICR via
caffeine resulted in a biphasic response, which may be due to activation of
depolarizing Cl channels and/or hyperpolarizing K* channels. (D) Blockade
of K* channels by TEA prevented caffeine’s inhibitory action, suggesting
that caffeine-induced CICR mediates K* channel opening. (E) Inhibiting SR
Ca** release via RyR using ryanodine abolished spontaneous Ca’*; waves
and contractility. (F) Inhibition of InsP3R mediated SR Ca’*release using 2-
aminoethoxy--diphenylborate (2-APB)increased baseline Ca’*; and gradually
abolished both Ca’*; waves and contractility.
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hypoplastic lung. When expressed as a % of high K” peak (120 mM)or as
a % of carbachol peak, Ca”*transientrelative amplitudes were significantly
increased in hypoplastic lungs at 37°C and at 27°C compared to normal
controls (Figure 4.4).
4.3.4 Hypoplastic lung ASM exhibits an enhancedsensitivity to
depolarising KCI solution
To investigate potential causes for the abnormal relative amplitude (and
frequency) of ASM Ca’";transients in hypoplastic lung, the dose-response
relationship was established for depolarising KCI solutions (10 — 140 mM)
and the resulting change of Ca’"; in hypoplastic and control lung primordia.
ASM Ca’; increased in response to one-minute applications of
depolarising KCl solution. This dose-responserelationship approximated a
sigmoidal curve. Hypoplastic lungs exhibited an enhanced sensitivity to
depolarising KCl solution than controls (greater elevations of Ca’*;
expressed as % of peak Ca** transient obtained). These differences were
significant at 40, 60 and 100 mM KCI (Figure 4.5).
4.3.5 Carbachol increases Ca”; in similar manner in both
normal and hypoplastic lung ASM
The difference in the magnitude of the Ca’; response to depolarizing KCl
suggests that normal and hypoplastic lung may differ in terms of voltage-
gated Ca’* channelfunctioning. To explore whether dysfunctional SR Ca”
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Figure 4.4. Amplitudes of Ca’’; transients in hypoplastic lung primordia
are elevated compared with controls.
highlighting the amplitude of Ca*"; transients in nitrofen (uppertrace) and
control (lower trace) lungs compared to 1 minute control applications of
depolarising high-K” solution or 100 4M carbachol. Data were obtained
at 27°C. (B) Amplitudes of Ca’*, transients in hypoplastic and control
lung primordia recorded at 37°C and 27°C. Data are presented as mean +
SEM.
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Figure 4.5. Dose-response curve illustrating the activation of the Ca’;
transient by depolarising high-K" solution (10 — 140 uM)in hypoplastic
lungs (circles) and control lungs (triangles). The dose-response curve
wasconstructed from the phasic componentonly of the activated Ca;
transient. The tonic component was inconsistent in hypoplastic (n = 10)
and control (n = 12) lungs. Data are presented as mean + SEM.
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release also contributes to increased amplitude of Ca’’; transients in
hypoplastic lung, Ca”*; responsesto carbachol (1, 10 and 100 uM) were
compared in normal and in nitrofen-exposed lung. In contrast to
applications of depolarising KCl solution, there were no significant
differences between hypoplastic and control lung primordia (Figure 4.6).
4.3.6 SR Ca” release does not differ significantly between
hypoplastic and control lung ASM
The role of SR Ca’ release was further investigated in hypoplastic lung
Ca’; transients by studying the effects of caffeine (facilitating calcium
induced calcium release via RyR) and carbachol(via inositol triphosphate
receptors (InsP3R)) on Ca’*; in Ca’*-free solution to eliminate Ca”*, entry).
First, high K* solution was applied (to generate a 100% reference for
Ca’*}); then, 2 minutes superfusion with Ca’*-free solution decreased Ca’",.
Application of 20 mM caffeine in Ca’'-free solution, transiently increased
Ca**; and produced brief tonic airway contraction without significant
difference from normal lung (Figure 4.7). Subsequent application of
carbachol (100 uM) in Ca*'-free solution for 1 minute generated high
amplitude Ca**; transients and sustained tonic contraction. The responsesin
hypoplastic lung did not differ significantly from normal lung.
Thus, in hypoplastic lung, increased plateau duration, reduced frequency
and elevated amplitude ofASM Ca’"; transients may be due to dysfunction
ofplasmalemmal ion channels,affecting, e.g., membraneand/ or action
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Figure 4.6. Bar chart illustrating the activation of the Ca’* transient by
the muscarinic agonist, carbachol (1 — 100 uM), in hypoplastic lungs
(white bars; n = 9) and control lungs (black bars; n = 9). Data are
presented as mean + SEM.
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Figure 4.7. Bar chart illustrating the Ca’; response to applications of
caffeine (20 mM in zero Ca’*, solution and 2 mM EGTA), carbachol
(100 M) and carbachol (100 uM in zero Ca**, solution and 2 mM
EGTA). High K” application (1 minute) was applied to generate a 100%
reference for [Ca”"].. Hypoplastic lungs are represented by white bars (n
= 8); control lungs are represented by black bars (n = 7). Data are
resented as mean + SEM.
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potentials.
4.4 Discussion
4.4.1 When do airway smooth muscle abnormalities develop in
CDH?
The hypoplastic lung and its susceptibility to barotrauma are key
determinants of survival in congenital diaphragmatic hernia (Smith efal.
2005). We have postulated that ASM function is important not only in
FGF-10 driven early lung morphogenesis but also in compliance-regulated
late prenatal lung growth and potentially in regulating remodelling
responses to ventilation. This overarching ‘smooth muscle’ hypothesisis
based upon several observations including: (i) ASM progenitors produce
FGF10 (Mailleux et al. 2005); (ii) ASM activity is coupled to embryonic
lung growthin vitro (Jesudasonet al. 2005); (iii) human and experimental
lung hypoplasia is associated with perinatal ASM dysfunction together
with decreased lung compliance (Yang et al. 2000; Belik et al. 2003); (iv)
neonatal lung responds to chronic positive pressure ventilation with a
combination of ASM dysfunction, impaired compliance and airway
remodeling (Jobe et al. 2001). This study examines the hypothesis that
ASM dysfunction observed near-term in human and experimental lung
hypoplasia is not merely a late sequel of lung compression bya visceral
hernia, but is instead an early indicator of (and perhaps contributor) to
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embryonic failure of lung growth.
4.4.2 Lung hypoplasia can be modelledin vitro
To test this, we have utilized the nitrofen model of CDH: embryonic lungs
exposedin utero to nitrofen display hypoplastic growth before the visceral
hernia supervenes (Jesudason et al. 2000). In contrast to the surgically
created lamb model of CDH,nitrofen-induced CDH permits investigation
of early pre-CDHevents in the developing hypoplastic lung (de Lorimieret
al. 1967).
4.4.3 Novel in-situ measurement of Ca‘; in whole hypoplastic
lung explants
In order to study early ASM dysfunction in embryonic lung explants, we
have used confocal imaging and photometric measurements of Ca’; for
two reasons. Firstly, novel in-situ Ca’; imaging is feasible in whole
embryonic lung explants; Ca’; transients are ce to underpin ASM
peristalsis in normal lung explants (Featherstone ef al. 2005). Secondly,
spontaneously contracting cultured lung explants of<0.5mm lengths do not
readily lend themselves to measurementof force.
4.4.4 Ca”*; signalling is abnormal in hypoplastic lungs prior to
development of CDH
Using these techniques we have shown that the Ca**; transients in
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hypoplastic lung exhibit significant abnormalities that together suggest a
lesion of ASM plasmalemmal ion channels and /or action potential
generation. Furthermore, we have shown that ASM peristalsis in
hypoplastic lung is underpinned by spontaneousregenerative Ca’*; waves
propagating via gap-junctions that are dependent on not only Ca", entry
but also Ca”; release.
Normal and hypoplastic ASM Ca”"; transients appear to be action potential
mediated given their characteristic 4-phase morphology, propagation speed
and transmission via gap junctions (Hashitani et al. 2001; Burdygaetal.
2002). Hence, prolongation of the plateau phase of Ca”*; transients at 37°C
and 27°C in hypoplastic lung ASM is likely to be due to alteration in the
action potential (Burdyga et al. 2002). Further support for a prolongation
of the action potential derives from the observed increase in relative
amplitude of the Ca*’; transients in hypoplastic lung (relative to KCI and
carbachol induced maxima) (Burdyga ef al. 2002). Underlying
abnormalities of membrane potential and ion channel functioning are also
suggested by the significant reduction observed in the frequency of Ca;
transients in hypoplastic lung at 27°C. (Burdyga et al. 2002). Again
consistent with an alteration in membrane potential / ion channel
functioning, hypoplastic lung exhibited an elevated sensitivity to
depolarizing KCI solutions. However, mechanismscontrolling initial entry
and/ or release of Ca”* andits subsequent SR uptake or extrusion from the
cell appear unaffected in hypoplastic lung: the rates of rise and relaxation
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of the Ca’’; transients at 37°C and 27°C are comparable between normal
and hypoplastic lung. Indeed, hypoplastic lung ASM appears to have
normal SR activity: Ca’*, dose-response to carbachol showednosignificant
difference between hypoplastic lungs and controls, even when Ca’’, entry
was eliminated. Similarly, there was no significant difference in the
caffeine response in hypoplastic and control lung primordia. Unequivocal
demonstration of the abnormalities of action and / or membranepotential
necessitates micro-electrode recording (Burdygaet al. 2002). However, the
embryonic lung presents considerable difficulties due to its small size and
mechanical activity dislodging micro-electrodes. However, in the adult rat
ureter preparation, prolongation of the plateau phase of the smooth muscle
Ca’; transient (by cooling) is similarly accompanied by increase in the
amplitude of the Ca*’; transient and elongation of the action potential
plateau phase (Burdygaet al. 2002).
4.4.5 Abnormalities of airway smooth muscle function may
unify the observed lung hypoplasia and late sequelae
(bronchial hyper-reactivity) in CDH
Embryonic nitrofen-exposed lung, therefore, features abnormal Ca;
transients that accompanyearly hypoplasia and precede supervention of the
visceral hernia. Since propagating Ca**; waves underpin ASM peristalsis
(Featherstone ef al. 2005), this indicates that ASM function is already
abnormal at the embryonic stages of hypoplastic lung development. The
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latter conclusion is significant given that a) ASM progenitors furnish the
FGF10 required for early branching morphogenesis; and b) nitrofen-
exposed lung primordia exhibit branching abnormalities in tandem with
FGF10-deficiency (Mailleux et al. 2005; Acostaet al. 2001). Together, this
supports the thesis that ASM contributes to early FGF10-driven lung
morphogenesis and that this relationship is disrupted prior to CDH
supervening. ASM dysfunction also persists after CDH develops: nitrofen-
exposed fetal lungs display increased ASM contractility and human CDH
survivors manifest reactive airways disease (Belik et al. 2003; Boaset al.
1996). Therefore, the embryonic ASM dysfunction we have shown
(increased duration and amplitude of embryonic ASM Ca’*; transients)
may underlie, in part, later post-CDH ASM abnormalities (airway hyper-
reactivity).
Having shown that early ASM dysfunction accompanies embryonic
growth failure and is consistent with late ASM lesions, it is worth
considering the mechanisms whereby ASM dysfunction might contribute
to impaired lung growth. The ‘smooth muscle hypothesis’ postulates that
ASM abnormalities may impair not only embryonic lung growth(related to
FGF10-producing ASM progenitors) but also fetal pulmonary growth (via
dysregulated lung compliance) (Jesudason 2006). This latter role of ASM
dysfunction in fetal and postnatal lung development merits review. ASM
contractility generates tension in the airway wall (Schittny et al. 2000).It is
reasonable to assume that such changes are accompanied byalterations in
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intraluminal pressure. The latter is known to influence several aspects of
lung cell and organ growth (Harding et al. 1996; Xu et al. 1998). Hence
ASM activity can plausibly affect lung growth by virtue of its wider
mechanical effects on lung compliance. Experimental support for this
concept emerges from observation that in vitro inhibition / stimulation of
Rho-associated kinase results in decreased / increased lung growth
respectively (presumably via modulation of cytoskeletal tension) (Moore ef
al. 2005). Certainly if unrecognised ASM dysfunction impairs compliance
of hypoplastic lung, one might expect more unpredictable results from
prenatal tracheal occlusion (Heerema ef al. 2003). Indeed the results of
tracheal occlusion in previously normal fetal lung may be less easily
extrapolated to effects in hypoplastic lung. Moreover the reported benefits
of dynamic rather than static tracheal occlusion may arise in part due to
simulation of the pressure waves generated by ASM peristalsis (Nelson et
al. 2005). Finally, if ASM participates in the regulation of neonatal lung
compliance, observed ASM dysfunction may help explain the increased
susceptibility of the hypoplastic lung to barotrauma (Wungef al. 1995).
4.5 Conclusions
a) ASM Ca*"; transients in hypoplastic lung primordia exhibit abnormal
temporal characteristics compared to control embryonic lungs.
These differences may be due to altered expression of membrane
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ion channels and/ or underlying action potentials.
b) ASM Ca’"; transients in hypoplastic lung primordia depend upon
Ca", entry and Ca" release.
c) ASM Ca"; transients in hypoplastic lung primordia propagate via
smooth muscle cells coupled by gap junctions.
d) ASM Ca?"; transients in hypoplastic lung are likely to be action
potential—mediated.
e) The observed abnormalities precede CDH and yet are congruent
with ASM dysfunction observed perinatally. We have proposed
that such early ASM lesions may be important to defective lung
development not only in embryogenesis but also in late fetal life
and following postnatal ventilation.
f) Testing this ‘smooth muscle hypothesis’ may therefore help us to
explain the survival benefits of limiting postnatal ventilatory
pressures and emphasise the need for similar consideration during
tracheal occlusion in human fetuses with CDH.
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Chapter 5
CYCLOPIAZONIC ACID REVERSIBLY
ABOLISHES LUNG BRANCHING
MORPHOGENESIS AND AIRWAY
PERISTALSIS
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5.1 Introduction
CDH retains high mortality due to pulmonary hypoplasia and
pulmonary hypertension (Smith ef al. 2005). Normal lung development
requires a variety of growth factors and a numberof mechanical factors.
Airway peristalsis (AP) is one such mechanical factor; it has been
recently reported to be coupled to lung growth in vitro (Jesudasonetal.
2005).
Wehavealready shownthat spontaneous regenerative propagating Ca’*;
waves underpin mechanical airway contraction in developing lungs
(Featherstone et al. 2005) and that these Ca**, waves were abnormalin
an experimental model of CDH (Featherstone et al. 2006). ASM Ca’;
waves underpinning spontaneous mechanical airway contraction (AP)
therefore appear to influence and regulate normal lung development.
Spontaneous ASM Ca**; waves require Ca”*, entry and Ca’’; release
(Featherstone ef al. 2005). Culturing lung explants in the presence of
nifedipine (an L-type Ca”* channel blocker that irreversibly inhibits
Ca’*, entry) results in lung hypoplasia but does not affect branching
(Roman, 1995; Jesudasonet al., 2005).
Given that spontaneous Ca**; ASM waves require both Ca’*, entry and
Ca”; release, in these studies, we abolished sarcoplasmic Ca”*; reuptake
using cyclopiazonic acid (CPA), a compound isolated from the fungus
Penicillium cyclopium (Holzapfel, 1968). We show CPA completely and
reversibly abolished lung branching morphogenesis. Sarcoplasmic Ca’*
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appearsessential to lung branching morphogenesis (whether due to release
via ryanodine (RyR) or inositol triphosphate (InsP3R) channels or re-
uptake via the SR Ca”*-ATPase (SERCA pump)).
5.2 Materials and methods
5.2.1 Retrieval of embryonic lung primordia
See section 3.2.1
5.2.2 Embryonic lung culture
Lung rudiments were positioned on translucent polytetrafluorethylene
membrane culture-dish inserts (Millicell, Millipore Corp, Bedford, MA)
with serum-free culture media incorporating penicillin (100 IU/ml) and
streptomycin (100 ug/ml; GibcoBRL, Life Technologies, Paisley, UK).
Lung primordia were incubated at 37°C in 5% CO) for periods up to 78
hours + CPA (20 uM). Additionally, some explants were exposed to CPA
after 30 or 54 hours in vitro; others were ‘rescued’ from CPA exposure
after 30 or 54 hours.
5.2.3 Assessmentofviability
See section 3.2.2
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5.2.4 Morphometric analysis of in vitro lung development
Lung explants were photographedat 0, 30, 54 and 78 hoursin vitro to track
growth and branching morphogenesis. Photographs were scanned into a
microcomputer and Scion Image Beta 4.03 software (Scion Corporation,
Frederick, Maryland, USA) was used to trace the epithelial contour from
each image in order to calculate the individual lung epithelial area and
perimeter. The number of terminal buds was also recorded at each time
point.
5.2.5 Immunohistochemistry
See section 3.2.6
5.2.6 Statistical analysis
See section 3.2.7
5.3 Results
5.3.1 CPA inhibits branching morphogenesis in embryonic
lung explants
Embryonic rat (n=8) and mouse lungs (n=8) cultured in the presence of
CPA exhibited inhibition of lung branching morphogenesis (Figures 5.1
and 5.2). Lung morphometry performed on rat lungs (Figure 5.3) showed
similar areas at 0 h (0.34 + 0.01 mm’vs. 0.35 + 0.01 mm”) but significantly
reduced specimenarea at 30 h (0.66 + 0.03 mm’vs. 0.39 + 0.01 mm”), 54
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Figure 5.1. Effect of cyclopiazonic acid (CPA) on the morphological
development of embryonic rat lung primordia in vitro.
Photomicrographs were taken at 30, 54 and 78 hours. CPA abolished
branching morphogenesis.
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Figure 5.2. Effect of cyclopiazonic acid (CPA) on the morphological
development of embryonic mouse lung primordia in vitro.
Photomicrographs were taken at 0, 30, 54 and 78 hours. CPA
abolished branching morphogenesis.
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Figure 5.3. Box plots illustrating the morphometric data for control rat
lungs cultured in serum-free medium (red); with rat lungs ‘rescued’
from CPA (20 uM) at 30 hours in vitro (yellow); with rat lungs
‘rescued’ from CPA (20 pM) at 54 hoursin vitro (green); and rat lungs
exposed to CPA (20 pM)for up to 78 hours (blue). Data are shown at0,
30, 54 and 78 hours. Bars represent medians and boxes’ interquartile
range. * Significant increase compared to lungscultured in the presence
ofCPA for 78 hours (P < 0.001).
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h (1.11 + 0.06 mm’vs. 0.41 + 0.02 mm’) and 78 h (1.09 + 0.06 mm” vs.
0.52 + 0.02 mm”) (p < 0.001). Likewise, specimen perimeter whilst the
same at 0 h (5.16 + 0.14 mm vs. 5.05 + 0.14 mm) was significantly
reduced at 30 h (8.33 + 0.18 mm vs. 5.47 + 0.17 mm), 54 h (11.34 + 0.15
mm vs. 5.69 + 0.20 mm) and 78 h (12.04 + 0.32 mm vs. 6.00 + 0.20 mm)
(p < 0.001). Total bud count was also abolished at 30 h (10.50 + 0.33 vs.
6.25 + 0.16), 54 h (17.29 + 0.78 vs. 6.38 + 0.18) and 78 h (24.25 + 1.16 vs.
6.50 + 0.19) (p < 0.001).
5.3.2 Lung explants removed from CPA resumebranching
Embryonic rat lung explants were ‘rescued’ from CPA exposure at 30 and
54 hours in vitro. Return to normal culture medium resulted in a return of
branching morphogenesis; there was an increase in the specimen areas,
perimeters andtotal bud counts (Figures 5.3 and 5.4).
‘Rescue’ at 30 hours increased (p < 0.001) specimen area, perimeter and
bud count at 78 hours compared to lungs cultured in the continued
presence of CPA. Specimen area was 0.73 + 0.03 mm” vs. 0.52 + 0.02
mm”; specimen perimeter was 8.54 + 0.21 mm vs.6.00 + 0.2 mm; andtotal
bud count was 14.50 + 0.50 vs. 6.50 + 0.19. In a similar manner, ‘rescue’at
54 hours in vitro, resulted in a statistically significant increase (p < 0.001)
in total bud count at 78 hours compared with lungs cultured in the
continued presence of CPA. Total bud count was 8.78 + 0.60 vs. 6.50 +
0.19%.
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Control CPA rescue CPA CPA for
30hr rescued54hr 72hr
 
Figure 5.4. Effect of ‘rescuing’ rat lung explants from cyclopiazonic
acid (CPA) on the morphological development of embryonic rat lung
primordia in vitro. Explants were ‘rescued’ at 30 or 54 hours. ‘Rescue’
from CPAresulted in re-establishment ofbranching morphogenesis.
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5.3.3 CPA inhibits branching morphogenesis if added to lung
explants at later time points in culture
To determine whether CPA application would abolish or reduce branching
morphogenesis at other time points in culture, we changed the culture
medium to one containing CPA (20 uM)at 30 hours (n = 8) or 54 hours (n
= 8) in vitro. As before, addition of CPA resulted in abolition of branching
morphogenesis in embryonic rat lungs (Figure 5.5 and 5.6). When CPA
was added at 30 hours, the total bud count did not increase significantly
with subsequent culture (54 hours: 18.13 + 0.91 buds; 78 hours: 20.25 +
1.10 buds (p = NS)). When lung explants were cultured in standard
medium, there was a significant increase in total bud count between 54 and
78 hours in vitro (54 hours: 17.29 + 0.78 buds; 78 hours: 24.25 + 1.16 buds
(P < 0.001)). Similar data were obtained with the addition of CPA to the
culture medium at 54 hoursin vitro.
5.3.4 CPA may delay morphological development
Our provisional data appears to suggest that CPA exposure delayed
morphological development; tracheal cartilage rings were clearly evident
upon light transmitted images of lung explants cultured in standard
medium for 78 hours, however, they failed to develop in lung explants
cultured in the presence ofCPA (Figure 5.7).
Given that CPA inhibited branching morphogenesis and delayed
morphological developmentin lung cultures, we considered thatits
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Control CPAat Ohr CPA at CPA at
30hr 54hr
 
Figure 5.5. Effect of adding cyclopiazonic acid (CPA)atlater stages of
culture upon the morphological development of rat lung primordia in
vitro. Explants were exposed to cyclopiazonicacid at 0, 30 or 54 hours.
Addition of cyclopiazonic acid to the culture medium resulted in
abolition of branching morphogenesis.
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Figure 5.6. Box plots illustrating the morphometric data for control
lungs cultured in serum-free medium (red); with cyclopiazonic acid (20
uM) addedat 30 hoursin vitro (cyan); and cyclopiazonic acid (20 uM)
added at 54 hoursin vitro (light blue). Data are shown at 0, 30, 54 and
78 hours. Bars represent medians and boxes’ interquartile range.
Significant increase (*P < 0.001, * P < 0.05) compared with previous 24
hours.
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Control CPA rescue 30hr
Time
Ohr
Time
30hr
Time
54hr 
Figure 5.7. Effect ofCPA acid (20 1M) onthe ontological development
of embryonic rat lungs in vitro. At 54 hours, control lungs display
collagen rings orientated parallel to the long axis of the trachea (arrow).
However, collagen rings are not apparent in those lungs exposed to
CPA for 30 hours and then ‘rescued’.
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application in vitro may also result in delayed physiological maturation.
ASM has been reported to be developmentally regulated (Jesudasonetal.
2005, Jesudason et al. 2006). At 30 h, spontaneous contractions primarily
originated from the second bronchial division of the right lung (R-waves)
and outnumbered those from the left lung (L-waves), which in-turn
outnumbered those from the trachea (T-waves). By 54 h and 72 in vitro,
T-wavespeter out in normal lung i.e. proximal ASM (T-waves) become
quiescent.
Consequently, quantification of the origin of contractile waves at 54 or 78
hours was undertaken in specimenscultured in the presence (n = 8) ofCPA
for 30 hours and then ‘rescued’ and in lungs cultured in standard media (n
= 7). As previously reported (Jesudason ef al. 2005, Jesudasonet al. 2006),
there was a decline in ‘T-wave’ activity in control specimens with time
(Figure 5.8). However, there was a persistence of “T-waves’ in lungs
cultured in the presence of CPA. This difference, however, did not reach
statistical significance (P = NS).
5.3.5 a-SMA expression is reduced after CPA application
As CPA inhibited both peristalsis and morphological development of the
embryonic lung, we wanted to determine its effect on airway smooth
muscle ontogeny. Wecultured rat lungs in standard culture solution with (n
= 8) or without CPA (n = 8). After 72 h in culture, lungs were fixed in
paraformaldehyde and processed for a-SMA immunohistochemistry. This
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Figure 5.8. Changing distribution of the origin of spontaneous
contractile waves with development. Data are shown for waves(rates of
contraction per minute) originating in the left lung (blue), trachea
(green, and right lung (light brown) at 54 hours (top) and 78 hours
(bottom) in vitro. Control rat lungs were cultured for 78 hours in
standard medium. ‘CPArescue’ rat lungs were cultured in the presence
of CPA until 30 hours and then returned to standard medium. Bars
represent means + SD.
146
showed that compared to normal lung explants, pulmonary a-SMA
expression wasreducedbyculture in the presence ofCPA (Figure 5.9).
5.3.6 CPA reducescell proliferation in cultured lung
Since culturing lungs in the presence of CPA resulted in inhibition of
branching morphogenesis, we were interested to determine whether its
effects were in part due to inhibition ofproliferation.
Brdu (5-bromo-2’-deoxyuridine) pulse labelling was performed to assess
cellular proliferation. CPA application resulted in statistically significant
reduction in cells labelling positive for Brdu at 24 hours in the end buds (p
< 0.001) and airway (p = 0.009). At 48 hours, although there was a
reduction in the proportion of cells labelling positively for Brdu in CPA
treated lungs, the differences observed were notstatistically significant (p
= NS). Figures 5.10 and 5.11 show the results. The results suggest that, in
vitro, CPA suppresses cellular proliferation at 24 hours, but not at 48
hours.
5.4 Discussion
CDHretains high morbidity and mortality; lung hypoplasia and pulmonary
hypertension are primarily responsible. To understand lung hypoplasia and
potential therapies to ‘rescue’ the CDH lung, it is first necessary to
appreciate the processes regulating normal lung development.
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Figure 5.9. Immunohistochemistry for a-smooth muscle actin. After
a period of 48 hours in vitro culture, control rat lung explants (top)
show normal a-smooth muscle actin expression; however, in lungs
exposed to CPA (bottom), the expression is abolished.
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Figure 5.10. The effect of cyclopiazonic acid (CPA) on cellular
proliferation as assessed by Brdu (5-bromo-2’-deoxyuridine) labelling
within the end-buds of embryonic rat lung explants. Data are shown at
24 (blue bars) and 48 hours (green bars) for control lungs and explants
cultured in the presence of CPA. CPA significantly reduced cells
labelling positively for Brdu at 24 hours, but not at 48 hours. Bars
represent means and SD.
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Figure 5.11. The effect of cyclopiazonic acid (CPA) on cellular
proliferation as assessed by Brdu (5-bromo-2’-deoxyuridine) labelling
within the airway of embryonic rat lung explants. Data are shown at 24
(blue bars) and 48 hours (green bars) for control lungs and explants
cultured in the presence of CPA. CPA significantly reduced cells
labelling positively for Brdu at 24 hours, but not at 48 hours. Bars
represent means and SD.
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Prenatal airway smooth muscle (ASM)peristalsis is a mechanical factor
that has been reported to be coupled to lung growth (Jesudason efal.,
2005). ASM peristalsis is underpinned by spontaneous regenerative
propagating Ca’*; waves, which in turn depend on Ca’*, entry and Ca’*,
release (Featherstone ef al., 2005). Thus if AP regulates lung growth,
airway smooth muscle Ca’; waves regulate prenatal lung morphogenesis.
5.4.1 CPA inhibits branching morphogenesis in embryonic rat
and mouselung explants
CPA inhibits removal of Ca’ from the cytoplasm of the cells by the
sarcoplasmic reticulum (SR) Ca*'-ATPase (SERCA pump); it is a
compound isolated from the fungus Penicillium cyclopium (Holzapfel,
1968). We have previously shown CPA markedly increases baseline Ca;
and gradually abolishes Ca’"; transients and associated mechanicalactivity;
phasic airwayactivity being gradually replaced by tonic airway contraction
(Featherstone et al., 2005). CPA empties the SR and prevents Ca** release
via ryanodine (RyR) channelsorinositol triphosphate (InsP3R) channels.
CPA abolished branching morphogenesis in both embryonic rat and mouse
lung explants whether applied at the beginning of the culture period or at
later time intervals. Our observations give further support to the thesis that
ASM contractility and Ca**; waves are a prerequisite for normal lung
development.
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Ca’*; pools have been previously shown to play a key role in controlling
vascular smooth muscle cell (VSMC)proliferation in vitro (Shukla et al.
1997). Similarly, Ca’*; inhibitors are capable of arresting cell growth in
DDT|MF-2 smooth muscle cells (Short et al. 1993). They suggest that
emptying the internal Ca’* pool maintainscells in a Go-like quiescentstate.
Onceintracellular pools refill, the cell cycle resumes. CPA may act in a
similar mannerresulting in inhibition ofthe cell cycle.
We showed that CPA inhibited branching morphogenesis. Nifedipine, in
contrast, does not inhibit branching (Roman, 1995; Jesudason et al., 2005).
These observations suggest that Ca**; waves and consequent ASM
peristalsis are perhaps necessary for lung growth, but not branching
morphogenesis. Inhibiting Ca’* release from the internal store abolished
lung branching morphogenesis and produced lung hypoplasia. Therefore,
Ca’* release from the SR via RyR channels or InsP3R channels appears
critical to lung branching morphogenesis. Inhibition of Ca’* release from
the SR may prevent dynamic temporo-spatial Ca*"; signalling (Berridge et
al., 2003; Lipskaia et al., 2004). Furthermore, CPA produces an elevation
in Ca’*; and tonic airway contraction (Featherstone ef al., 2005). Previous
investigators have shown that modulating cytoskeletal force also plays an
important role in epithelial branching morphogenesis (Mooreet al., 2005).
CPA application may therefore increase cell tension; excess tension may
result in contraction and cessation of organ development (Moore ef al.,
2005).
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5.4.2 ‘Rescue’ of lung explants from CPA exposure results in a
return of branching morphogenesis
Removal of CPA from the system results in a return of spontaneous
contractile ASM activity and branching morphogenesis. These data
indicate that the SR controls ASM contractile activity and provides further
evidence that the SR appears to play a crucial role in the control of
epithelial branching morphogenesis. In particular, the SR Ca’*-ATPase
(SERCA pump)playsa central role. It is required to remove Ca’* from the
cytoplasm and permit refilling of the SR (Sanders 2001; Taylor ef al.
2002). These data also give further support to the thesis that spontaneous
airway contractile activity is required for normal lung development.
The abolition of lung branching morphogenesis by CPA may be due to
several mechanisms e.g. 1) abrogation of SR Ca** release; 2) marked
elevation of Ca”vs 3) increased ASM tone and/ or 4) direct CPA-effects on
the cell cycle.
5.4.3 CPA application results in morphological delays in
development
CPA application appeared to delay morphological development; tracheal
cartilage rings were clearly evident upon light transmitted images of rat
lung explants cultured in standard medium for 78 hours, however, they
failed to develop in explants cultured in the presence of CPA. CPA may
153
also delay physiological development; normally ASM peristalsis is
developmentally regulated with early T-wave activity being gradually
replaced by L- and R-waves (Jesudason ef al. 2006). Hypoplastic lungs,
deficient in FGF-10, exhibit retardation of this developmental regulation
(Jesudason et al. 2006). We re-established that ASM peristalsis is
developmentally regulated in control lungs. However, lungs exposed to
CPA for 30 hours prior to rescue, continued to exhibit T-waves at 54 and
78 hours. These data did not reach statistical significance and further
studies are required to determine the effects of CPA on the developmental
regulation of AP.
5.4.4 a-SMA expressionis reduced after CPA application
Smooth muscle actin expression in human lung and other animals is
developmentally regulated throughout gestation (Jostarndt-Fégen et al.,
1998; Sparrowefal., 1999; Tollet et al., 2001; Yamada etal., 2002). ASM
cells develop from the mesenchymedirectly underlying the epithelium at
the base of the epithelial buds (Sparrow et al. 2003; Mailleux et al. 2005).
In our experiments, a-SMA expression was reduced in lung explants
exposed to CPA. This was associated with a loss of branching
morphogenesis. This gives further support to the thesis that SM activity is
required for prenatal lung developmentandnot merely the “appendix of the
lung’ (Mitzner 2004; Jesudasonet al., 2005; Jesudason, 2006).
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5.4.5 CPA reducedcellular proliferation at 24 hours in vitro
Ca*’; inhibitors, thapsigargin and di-tert-butylhydroquinone have been
shown to inhibit cell proliferation in vitro (Short et al., 1993). Likewise,
CPA may have a similar effect. There was a significant reduction at 24
hours of proliferation in both end budsand airway, but not at 48 hours (the
bioavailability of CPA may alter over time, cellular resistance may
develop, metabolism mayalter, or novel Ca** influx channels could appear
and lead to a resurgence in proliferation). These data may in part explain
the inhibition of branching morphogenesis. However, the control of
branching morphogenesis is complex, CPA may also affect cytoskeletal
tension which mayitself inhibit branching (Moore ef al., 2005). Further
work is needed to investigate further the relationship between CPA,
proliferation / the cell cycle and branching morphogenesis.
5.5 Conclusions
a) SERCA pumpinhibition with CPA reversibly abolished airway
peristalsis, abrogated branching morphogenesis and inhibited
aSMA expression; it also impaired development of cartilage
tracheal rings and induced a transient reduction in pulmonary cell
proliferation. Together these findings support a key role of prenatal
sarcoplasmic Ca*" signalling in lung morphogenesis, contractility
[53
b)
d)
and cell fate. They also indicate that the ‘growth arrest’ induced by
CPA is not simply due to inhibition of lung cell proliferation.
Therefore, the SERCA pump appearsto play critical role in lung
growth and epithelial branching morphogenesis.
Release of Ca”* from the SR via RyR channels or InsP3R channels
appears to be central to branching morphogenesis. CPA completely
abolished branching morphogenesis (in contrast to nifedipine,
whichresults in lung hypoplasia alone).
Inhibition of the SR Ca’*-ATPase significantly reduced cellular
proliferation at 24 hours in vitro. CPA may empty the Ca**; pool
resulting in cells entering a quiescent state and reduced cellular
proliferation. Re-establishment of branching morphogenesis upon
‘rescue’ from CPA exposureis consistent with this theory.
CPA results in an ontological delay in lung development, whichis
consistent with a reduction in cellular proliferation and delayed
lung growth.
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Chapter 6
EFFECTS OF SUCROSEANDNIFLUMIC ACID
UPON AIRWAYPERISTALSIS,Ca”;
TRANSIENTS AND LUNG MORPHOLOGY
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6.1 Introduction
Pulmonary hypoplasia and pulmonary hypertension account for the high
mortality in newborns with congenital diaphragmatic hernia (Smith efal.
2005). Consequently, surgeons have attempted to improve the outcome for
CDH newbornsby improving lung growth through fetal tracheal occlusion
(Harrison et al. 2003; Deprest et al. 2005; Kitano, 2007). However, this
technique is not without problems; it expands the lung, but also results in
abnormaldifferentiation (Lipsett et al. 1998), depletion of alveolar type II
cells (De Paepe ef al. 1998) and surfactant deficiency (O’Toole et al.
1996). Repeated cyclical occlusion and release appears to promote
maturation and developmentofa saccular lung (Nelson etal. 2005).
Similarly, in vitro, it has been demonstrated that over-accumulation of lung
fluid disrupts lung branching morphogenesis (Nogawa ef al. 2002).
However, mechanical drainage or osmotic manipulation of the lung culture
medium using sucrose, NaCl, or lactose reduces luminal distension and
stimulates branching morphogenesis (Nogawa et al. 2002). Since
spontaneous contractile activities of the musculature of the embryonic
airways (airway peristalsis) have been reported to be coupled to lung
growth in vitro (Jesudasonet al. 2005), we were interested to determine the
effect of manipulation of luminal lung fluid (by changing osmotic
conditions) upon airway peristalsis in our experimental model; the data
obtained may have implications for therapies such astracheal occlusion.
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Throughout gestation, lung liquid is produced; it is central to pulmonary
development andarises as a result of the continued secretion of chloride
(Cl) (McCray ef al. 1992). The Ca**-activated Cl channel is one of a
number of Cl channels implicated as being involved (Clarke ef al. 1994).
Wesought to determine the effect of niflumic acid, known to inhibit Cl’
conductances (White et al. 1990; Korn et al. 1991; McCarty et al. 1993),
on lung branching morphogenesis and ASM Ca**; waves in our
experimental model.
We show that the manipulation of osmotic pressure using sucrose
improved branching morphogenesis, but decreased the frequency of
spontaneous contractions. Niflumic acid stimulated branching
morphogenesis, increased the frequency of spontaneous contractions and
reduced the amplitude ofASM Ca’*; waves.
6.2 Materials and methods
6.2.1 Retrieval of embryonic lung primordia
See section 3.2.1
6.2.2 Embryonic lung culture
Lung rudiments were positioned on translucent polytetrafluorethylene
membrane culture-dish inserts (Millicell, Millipore Corp, Bedford, MA)
with serum-free culture media incorporating penicillin (100 IU/ml) and
streptomycin (100 pg/ml; GibcoBRL, Life Technologies, Paisley, UK).
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Lung primordia were incubated at 37°C in 5% CO for periods up to 78
hours + sucrose (20, 30, 50 or 100 mM)or niflumic acid (10, 50 or 100
uM).
6.2.3 Assessmentofviability
See section 3.2.2
6.2.4 Morphometric analysis of in vitro lung development
See section 5.2.4
6.2.5 Analysis of spontaneousairwaycontractility
The frequency of spontaneous airway contractions were recorded in
individual lung explants for 10-minute periods at 37°C as previously
described (Jesudason et al. 2005). Inter-contraction intervals were
calculated from the data obtained.
6.2.6 Loading lung explants with Ca”*; sensitive fluophores
See section 3.2.3
6.2.7 Photometric measurements
See section 3.2.4
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6.2.8 Solutions
Unless otherwise stated, lung explants were superfused at 37°C with
buffered physiological saline (pH 7.4) containing (mM): 120 NaCl, 5.6
KCI, 0.12 MgSO, 2 CaCl, 11.7 glucose, 10.9 HEPES. Other additions to
standard superfusate that were investigated include: carbachol (100 uM)
and high K* solution (120 mM). Carbachol was dissolved in distilled
water. Sigma (Poole, Dorset, UK) supplied all chemicals.
6.2.9 Statistical analysis
See section 3.2.7
6.3 Results
6.3.1 Sucrose increases lung branching morphogenesis
Lung explants were cultured in either standard culture medium (n = 6) orin
medium to which sucrose had been addedto give a final concentration of
20, 30, 50 or 100 mM (n = per group). In a similar manner to that
reported by Nogawaef al. in 2002, the addition of sucrose to the standard
culture medium stimulated branching morphogenesis (Figure 6.1)
(Nogawa et al., 2002). Figure 6.2 shows the morphometric results
(specimen area, specimen perimeter and total bud count) for lungs cultured
in standard media and sucrose media. Lungs cultured in the presence of
100 mMsucrose exhibitedstatistically significant increases (p < 0.001) in
the specimen perimeter (17.27 + 0.64 vs. 11.48 + 0.55 mm) and total bud
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Control Sucrose Sucrose Sucrose Sucrose
20 mM 30 mM 50 mM 100 mM
 
Figure 6.1. Effect of sucrose (20, 30, 50 and 100 mM) on the
morphological development of embryonic rat lung primordia in vitro.
Photomicrographs were taken at 0, 30, 54 and 78 hours. Sucrose
stimulated branching morphogenesis.
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Figure 6.2. Box plots illustrating the morphometric data for control
lungs cultured in serum-free medium (red); with sucrose 20 mM
(yellow); with 30 mM sucrose (green); 50 m sucrose (blue); and 100
mM sucrose (purple) at the corresponding time points 0, 30, 54 and 78
hours in vitro. Bars represent medians and boxes’ interquartile range.*
Significant increase comparedto control lungs (p < 0.001).
count (49.50 + 2.63 vs. 21.00 + 1.93) compared to control lungs after 78
hours ofin-vitro culture.
6.3.2 Sucrose reducesairwayperistaltic frequency
Inter-contraction intervals were calculated for control lungs and explants
cultured in the presence of sucrose (20, 30, 50 and 100 mM)at time 30, 54
and 78 hours in vitro. The frequency of spontaneous airway contractions
(airway peristalsis) was significantly decreased (compared to controls) in
embryonic lung explants cultured in the presence of sucrose at the time
points studied despite exhibiting increased branching morphogenesis
(Figure 6.3).
6.3.3 Niflumic acid increases lung branching morphogenesis
Lungs were cultured in standard culture medium or in media to which
niflumic acid had been addedto give a final concentration of 10, 50 or 100
uM. Figure 6.4 shows that the addition of niflumic acid to the standard
culture medium produced a dose-dependent increase in lung branching
morphogenesis. Morphometric data obtained at time 0, 30, 54 and 78 hours
in vitro is shown in Figure 6.5. Lungs cultured in the presence of niflumic
acid showed a marked increase in branching morphogenesis (increased
specimen perimeter, elevated total bud count and reduced specimenarea).
There werestatistically significant differences between explants cultured in
the presence of niflumic acid and controls (Figure 6.5).
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Figure 6.3. Box plots illustrating the intercontraction intervals
(seconds) at 30, 54 and 78 hours in vitro. Data are shown for control
lungs cultured in serum-free medium (red); with sucrose 20 mM
(yellow); with 30 mM sucrose (green); 50 mM sucrose (blue); and 100
mM sucrose (purple). Bars represent medians and boxes’ interquartile
range. Sucrose 100 mM significantly increased inter-contractile
intervals compared to control lungs at 30, 54 and 78 hours (*p < 0.05,
#p < 0.01).
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Control Niflumic Niflumic Niflumic
acid 10 acid 50 acid 100
uM uM
 
Figure 6.4. Effect of niflumic acid (10, 50 and 100 pM) on the
morphological development of embryonic rat lung primordia in vitro.
Photomicrographs were taken at 0, 30, 54 and 78 hours. Niflumic acid
stimulated branching morphogenesis and reduced luminaldistension.
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Figure 6.5. Box plots illustrating the morphometric data for control
lungs cultured in serum-free medium (red); with niflumic acid 10 hM
(yellow); with 50 uM niflumic acid (green); 100 uM niflumic acid
(blue) at the corresponding time points 0, 30, 54 and 78 hours in vitro.
Bars represent medians and boxes’ interquartile range. * Significant
increase compared to lungs cultured in serum free medium (p < 0.05). #
Significant decrease compared to lungs cultured in serum free medium
(p < 0.05).
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6.3.4 Niflumic acid reduces airway peristalsis inter-contraction
intervals
Given niflumic acid stimulated branching morphogenesis, and airway
peristalsis has been reported to be correlated with lung growth, we were
interested to determine whetherit had an effect on airway peristalsis. The
frequency of spontaneousairway contractility was statistically significantly
increased (p = 0.022) in explants exposed to media containing 100 uM
niflumic acid after 78 hours (Figure 6.6).
6.3.5 Niflumic acid reduces the amplitude of ASM Ca”*; waves
Wewerealso interested to determine the effect of niflumic acid exposure
upon the amplitude of ASM Ca**; waves in lung explants. Although
numbers were small (control = 2; niflumic acid 10 uM = 1; niflumic acid
50 uM = 2; and niflumic acid 100 uM = 2), there was a clear reduction in
the relative amplitude of ASM Ca*"; transients (Figure 6.7). These findings
may have becomestatistically significant should sufficient experimental
data been gathered. Consistent with this finding, video images of
contractions in control lungs and explants exposed to niflumic acid show
the relative amplitudes of contraction to be less in the treatment group.
6.4 Discussion
In order to develop new putative rescue therapies for congenital
diaphragmatic hernia (CDH)or improveexisting therapiese.g. tracheal
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Figure 6.6. Box plots illustrating the intercontraction intervals
(seconds) at 30, 54 and 78 hours in vitro. Data are shown for control
lungs cultured in serum-free medium (red); with niflumic acid 10 nM
(yellow); with 50 uM niflumic acid (green); and 100 1M niflumic acid
(blue). Bars represent medians and boxes’ interquartile range. Niflumic
acid (100 1M) significantly decreased the inter-contractile interval at 78
hours comparedto control lung (*p < 0.05).
169
 on Oo |
_ oO l
Ww T
No 1   
° |
| |
control niflumic niflumic niflumic
10 50 100
am
pl
it
ud
e(
%o
fp
ea
kC
a2
+t
ran
sie
nt)
oO |   
Figure 6.7. Effect of niflumic acid (10, 50 and 100 uM ) on ASM Ca;
wave amplitude. The amplitude of the spontaneous Ca*"; transients are
expressed as a percentage of the peaks obtained with 120 mM K*
solution (blue) or 100 uM carbachol (green). Bars represent medians
and boxes’ interquartile range.
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occlusion,it is first necessary to appreciate the processes regulating normal
lung development.
6.4.1 Sucrose increases lung branching morphogenesis
Nogawaetal. (2002) have previously shown that the addition of sucrose to
culture medium stimulates branching morphogenesis and reduces luminal
distension (Nogawaef al., 2002). Our results were in-keeping with their
published data. They postulated sucrose may either act as a nutrient or
generate osmotic pressure such that water moves by osmosis from the
luminal fluid to the culture medium. They provided further evidence for
the latter by increasing osmotic pressure with lactose or sodium chloride.
Draining lung liquid mechanically also stimulated branching
morphogenesis in their experimental model. Together, their results
suggested that over-accumulation of lung fluid disrupts lung branching
morphogenesis. These findings may have important implications for
tracheal occlusion. Over-distension of the airways may impair lung
development. Indeed, tracheal occlusion expandsthe lung,but also results
in abnormal differentiation (Lipsett et al. 1998), depletion of alveolar type
II cells (De Paepe ef al. 1998) and surfactant deficiency (O’Toole ef al.
1996). Repeated cyclical occlusion and release promotes maturation and
developmentofa saccular lung (Nelsonet al. 2005).
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6.4.2 Sucrose reducesairwayperistaltic frequency
Airway peristalsis has previously been reported to be coupled to lung
growth (Jesudason ef al. 2005). Modulating lung growth resulted in
parallel changes in airway peristalsis and vice versa. However, culturing
lungs in the presence of sucrose resulted in a significant slowing of
spontaneous ASM activity despite stimulation of branching
morphogenesis. Why should this be the case? It is possible that the
relationship between airway peristalsis and lung growth maynot be as
clear as previously reported. Some of the observed responses may be
secondary to other effects on airway smooth muscle e.g. depolarisation of
membranepotential / activation of ionic channels. In a similar manner,
sucrose may reduce smooth muscle activity although branching
morphogenesis is increased, as a consequence of the alteration in
osmolality. Changing extracellular osmolality has been shown to lowerthe
frequency of spontaneous contractions in detrusor smooth muscle strips
(Proctor et al. 1999).
6.4.3 Niflumic acid increases lung branching morphogenesis
and reducesairwayperistalsis inter-contraction intervals
Lung liquid production throughout gestation is central to pulmonary
development andarises as a result of the continued secretion of chloride
(McCray et al. 1992). It remains unclear as to which CI channels are
involved. Although the CFTR channel is an essential Cl channel, patients
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with cystic fibrosis (CF) have normal lung morphologyat birth (Sturgess et
al. 1982), suggesting other Cl channels may be involved in lung fluid
production. Other candidate channels include Ca’*-activated Cl’ channels
(Clarke et al. 1994), outward rectifying Cl channels (Gabriel et al. 1993),
or membersof the voltage-gated CLC family of Cl channels (CLC-2, -3
and -5) (Murray et al. 1995; Lamb ef al. 2001; Blaisdell et al. 2000;
Edmondset al. 2002; Blaisdell et al. 2004).
Niflumic acid, a non-steroidal anti-inflammatory aromatic compound
(Hoffmann et al. 1966; Kohler et al. 1992) is a known inhibitor of Ca’*-
activated Cl channels (White et al. 1990; Korn et al. 1991; McCartyet al.
1993). Niflumic acid stimulated lung branching morphogenesis (total bud
count, specimen perimeter and specimen area) and ‘rescued’ lungs from
the development of cystic morphology. Lung explants in our culture
system exhibit cystic morphology after 78 hours of in vitro culture
(Jesudason et al. 2005). This may berelated to the culture system in use
and also in part to the system being ‘closed’; the trachea spontaneously
seals within the first 24 hours of culture replicating tracheal occlusion. As a
consequence, secreted lung fluid accumulates within the principal airways
and terminal buds. Over-distension may inhibit branching morphogenesis
(Nogawaetal. 2002; Moore etal., 2005).If Ca**-activated CI channels are
involved in lung fluid production as proposed by Clarke ef al. (1994),
niflumic acid blockade, should reduce lung fluid production via these
channels and lung branching morphogenesis should increase as a
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consequence (Clarke ef al., 1994). Certainly, our data appear to confirm
that Ca’*-activated Cl channels play a role in lung fluid production as
niflumic acid exposure reduced luminal distension and augmented lung
branching morphogenesis (Figures 6.4 and 6.5).
Niflumic acid exposure was also associated with an increase in the
frequency of airwayperistalsis in lung explants. These data correlate well
with the observations of Jesudason ef al. (2005) who reported that
augmented lung growth is associated with an increase in peristaltic
frequency (Jesudason et al., 2005). However, the frequency of airway
peristalsis (and ASM Ca*'; waves) and the amplitude of ASM Ca**; waves
maybeclosely interrelated. Analogous to bowel obstruction in vivo, over-
distension ofthe airways mayresult in decreased peristaltic frequency (and
increased ASM Ca’‘, wave amplitude). Following this thesis, reducing
lung fluid production with niflumic acid and decreasing airway distension
should result in an increased peristaltic frequency (and reduction in Ca*j
wave amplitude). Our data are in-keeping with this theory. Likewise, co-
culture of lung explants with FGF-10 reduced spontaneous airway
contractility and increased ASM Ca’*, amplitude (data not shown), which
may be a response to stimulation of lung fluid production and airway
distension.
Another possibility to consider is that niflumic acid may exhibit cross
reactivity and/or alter ionic currents such that airway peristalsis is
stimulated. There are important caveats associated when using CI channel
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blockers such as niflumic acid as they show low potency, low selectivity,
tissue variability and can affect other ion channels (Greenwood ef al.
2007). It is well established that niflumic acid can stimulate large
conductance Ca*"-activated K* channels (BKca) at similar concentrations
to those required to block Ca’*- activated Cl channels (Greenwoodetal.
1995; Tomaet al. 1996). However, stimulation of BKc, channels would
result in decreased frequency of ASM contraction as tetraethylammonium
(TEA)blockade of K* channels is known to augmentperistaltic frequency
(Featherstone et al. 2005; Featherstoneet al. 2006).
6.4.4 Niflumic acid reduces the amplitude of ASM Ca”*, waves
Although overall numbers were small in our preliminary data set, we
observed that the relative amplitude of ASM Ca’*, waves decreased in lung
explants cultured with niflumic acid. This coincided with increased
branching morphogenesis and reduced distension of the embryonic
airways. It was also evident that the relative amplitude of the visualised
contractions became less. One hypothesis (as above) is that airway
distension secondary to lung fluid production results in decreased
frequency and increased amplitude ofASM Ca**; waves.
Vs
6.5 Conclusions
1) Sucrose increased lung branching morphogenesis but reduced the
frequency of ASM contractility in our experimental model.
Alteration of osmolality may be responsible for the decreased ASM
contractility. These data illustrate that lung development and
airwayperistalsis are not always coupledin vitro.
2) Ca’*-activated Cl channels appear to play a role in lung liquid
production in the developing embryonic rat lung. Niflumic acid
reduced luminal distension and stimulated lung branching
morphogenesis.
3) Niflumic acid exposure stimulated lung branching morphogenesis
and increased the frequency of ASM contractility, supporting the
thesis that ASM activity may be coupled to lung growth in vitro.
4) Considering tracheal occlusion for CDH, these data suggestthatit is
necessary to determine the optimal pressure for normal lung
development. If airway distension occurs through tracheal
occlusion, deleterious effects on lung growth will occur.
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Chapter 7
CLOSING REMARKS & FUTURE DIRECTIONS
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7.1 Overview
Congenital diaphragmatic hernia (CDH) retains high mortality mainly
because of pulmonary hypoplasia and pulmonary hypertension (Smith ef
al. 2005). As a consequence, many researchers have chosen to study
pulmonary development in order to gain greater insights into the factors
that control / influence lung development.
This thesis was based upon the knowledge that pulmonary hypoplasia is
one of the major determinants of mortality in CDH. Recently, spontaneous
airway contractility (airway peristalsis) has been shown to be coupled in
lung growth in vitro (Jesudason et al. 2005). Ca’* appears to play an
important role in airway peristalsis (McCray 1993; Sparrow ef al. 1994;
Roman 1995). Thus if airway peristalsis controls lung growth and Ca’*
underpins airway peristalsis, then ultimately, Ca**; waves drive lung
growth.
7.1.1 Ca”*; waves maydrive lung development
Peristaltic contractions of the prenatal airway are produced by spontaneous,
regenerative, temperature-dependent Ca”; oscillations of myogenic origin
that require extracellular Ca** influx, sarcoplasmic Ca’*; uptake, Ca’*;
release via RyR and InsP3R channels, and propagate via ASM cells in a
gap junction-dependent manner that is likely to be action potential—
mediated (Featherstone et al. 2005). Therefore, if as recent data suggest,
AP regulates prenatal lung growth (Jesudason ef al. 2005), then from the
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present study we can assert that intercellular Ca’’; oscillations in turn
regulate antenatal lung development (Featherstone et al. 2005;
Featherstone ef al. 2006; Jesudason 2006); propagation of intercellular
Ca*"; oscillations throughout a complex developing organ maybeintegral
to, and help coordinate, morphogenesis.
7.1.2 Ca”*; signalling is abnormal in hypoplastic lungs prior to
development of CDH
Ca*"; transients in hypoplastic lung ASM exhibit significant abnormalities
during embryogenesis (Featherstone et al. 2006); the temporal
characteristics of hypoplastic lung ASM Ca’*; transients were altered
compared to control ASM Ca’*, transients at both 37°C and 27°C.
Hypoplastic lung ASM Ca’', transients showed an elongation of the
plateau phase compared to normal control lung which was accentuated by
cooling to 27°C and accompanied by a significant reduction in the
frequency of Ca?*; oscillations. Additionally, the relative amplitudes of
Ca”; transients were significantly increased in hypoplastic lungs at 37°C
and at 27°C compared to normal controls. Hypoplastic ASM also exhibited
enhancedsensitivity to depolarising KCIsolution.
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7.1.3 Abnormalities of airway smooth muscle function may
unify the observed lung hypoplasia and late sequelae
(bronchial hyper-reactivity) in CDH
Embryonic nitrofen-exposed lung, therefore, features abnormal Ca”*;
transients that accompany early hypoplasia and precede supervention of the
visceral hernia (Featherstone et al. 2006). Since propagating Ca’*; waves
underpin ASM peristalsis (Featherstone et al. 2005), this indicates that
ASMfunction is already abnormal at the embryonic stages of hypoplastic
lung development. This is significant given that a) ASM progenitors
furnish the FGF10 required for early branching morphogenesis; and b)
nitrofen-exposed lung primordia exhibit branching abnormalities in tandem
with FGF10-deficiency (Mailleux et al. 2005; Acosta et al. 2001).
Together, this supports the thesis that ASM contributes to early FGF10-
driven lung morphogenesis and that this relationship is disrupted prior to
CDHsupervening (Featherstone ef al. 2006; Jesudason 2006; Jesudason et
al. 2006). ASM dysfunction also persists after CDH develops: nitrofen-
exposed fetal lungs display increased ASM contractility and human CDH
survivors manifest reactive airways disease (Belik et al. 2003; Boaset al.
1996). Therefore, the embryonic ASM dysfunction we have shown
(increased duration and amplitude of embryonic ASM Ca** transients) may
underlie, in part, later post-CDH ASM abnormalities (airway hyper-
reactivity).
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7.1.4 Blockade of Ca”*; release using CPA abolishes AP and
branching morphogenesis
CPA abolished branching morphogenesis in both embryonic rat and mouse
lung explants whether applied at the beginning of the culture period or at
later time intervals. It was associated with decreased expression of a-ASM
and delays in morphological and physiological development. These
observations give further support to the thesis that ASM,airwayperistalsis
and Ca’*; wavesare a prerequisite for normal lung development.
7.1.5 Reduction of lung fluid production via alteration of CI
secretion (niflumic acid) results in ‘coupled growth’
Niflumic acid application resulted in ‘coupled growth’; there was an
increase in both lung branching morphogenesis and airway peristalsis.
Given that niflumic acid decreased luminal distension within lung explants,
Ca**-activated Cl channels appear to play a role in lung liquid production
in the developing embryonicrat lung.
7.1.6 Reduction of lung fluid production through osmotic
modulation (sucrose) results in ‘uncoupled growth’
Osmotic modulation (sucrose) resulted in ‘uncoupled growth’; there was
an increase in lung branching morphogenesis but reduction in the
frequency of ASM contractility. These contrasting findings (section 7.1.5
and 7.1.6) suggest that further investigation is warranted into the
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relationship between lung liquid production, airway peristalsis and
pulmonary development. However, considering tracheal occlusion for
CDH, these data suggest that it is necessary to determine the optimal
pressure for normal lung development. If airway over-distension occurs
through tracheal occlusion, deleterious effects on lung growth will occur
(Silver et al. 1988; Heeremaetal. 2003).
7.2 Future Work
1. Ca**; imaging is a fast moving subject and it is hard to predict
technological advances that will occur in the future. However, there
have been many advances in the construction of genetically encoded
probes that permit optical imaging of activity in excitable cells
(Rizzuto et al. 1992; Rizzuto et al. 1994). This is possible through the
fusion of fluorescent proteins to proteins involved in physiological
signalling, such as those that monitor Ca**;, pH and membrane
potential. Through the use of specific promoters and targeting signals,
the probes are introduced into an intact organism and maybedirected
to specific tissues, cell types or sub-cellular locations. This permits
specific signals to be studied more efficiently and relevantly than
previously. In this manner, Ca’’; signalling and its controlling factors
could be further investigated in a complex organ suchasthe lung.
2. We have demonstrated that airway peristalsis relies in part upon Ca’*;
release (Featherstone et al. 2005; Featherstone et al. 2006). Blockade
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of the SERCA pump (SR Ca’'-ATPase) using cyclopiazonic acid
(CPA) abolished airway peristalsis and branching morphogenesis.
However, its mechanism of action is not fully understood and merits
further investigation. The observed effects may be due to inhibition of
the cell cycle (Short et al. 1993; Shukla ef al., 1997), abolition of
smooth muscle development or development of increased tension
within the smooth muscle (Mooreef al. 2005).
It is well-established that lung liquid production is related to lung
growth. Chronic drainage of lung fluid via a tracheostomy in utero
results in lung hypoplasia (Alcorn et al. 1977). In contrast, congenital
laryngeal obstruction results in hyperplastic lungs (Fewell et al. 1983).
Fetal tracheal occlusion has been utilised to correct lung growth in
utero (Hedrick et al. 1994; Bealer et al. 1995; Skarsgard et al. 1996;
VanderWall et al. 1996; Beierle et al. 1996; Harrison et al. 2003;
Heeremaet al. 2003; Keller et al. 2004; Deprest et al. 2005; Saura et
al. 2007). Howeverits effects upon airwayperistalsis are not clear. In
these studies we have shown that niflumic acid, an inhibitor of Cl
channels, increases both lung growth and airway peristalsis (i.e.
‘coupled growth’). In contrast, the use of sucrose to manipulate the
osmotic concentration of the culture medium increases lung growth,
but the frequency of airway peristalsis is reduced (i.e. ‘uncoupled
growth’). Could airwayperistalsis-related Cl-efflux perhaps drive Cl-
led lung fluid production (Figure 7.1), explaining these differences?
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Control
Sucrose
Niflumic acid  
Figure 7.1. Airwayperistalsis-related Clefflux (from ASM) maydrive
Cl-led lung fluid production. Whilst both sucrose and niflumic acid
reduce lung fluid (and here favour airway branching over dilatation),
interference with Cl transport (niflumic acid) prompts homeostatic
increases in AP (+++) whereas osmotic manipulation (sucrose) does not
(+).
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Further research is required to elucidate how airway peristalsis and
lung growth are related. Further investigations could also look at the
relationship between lung liquid production and Ca*"; transients. When
niflumic acid is used to improve lung growth, the amplitude of Ca’*,
transients became less in our preliminary experiments. This is in-
keeping with the findings within the hypoplastic lung, in which the
amplitude of Ca’’; transients were greater than normal lung, but the
frequency of peristalsis was less. One may therefore hypothesise that
airway fluid production, airway peristalsis and lung growth is
intimately related (Figure 7.2). Perhaps, balloon tracheal occlusion may
affect airway peristalsis and therefore lung growth in a detrimental
manner.
7.3 Closing Remarks
The care of newborns with congenital diaphragmatic hernia remains a
challenge to all involved. Advances have been made in ventilatory
techniques and clinical research demonstrated improved outcomes as a
result (Wung et al. 1995). New ventilatory therapies (e.g. liquid
ventilation) merit further investigation as they may ameliorate barotrauma
and promote lung growth (Hirschl ef al. 2003). Fetal interventions are
under trial (having been translated from “bench to bedside’) to improve
hypoplastic lung function and growth (Harrison ef al. 2003; Deprest et al.
2005). Despite promising experimental and preliminary clinical data,
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Figure 7.2. Putative regulation of lung growth by ASM activity via
feedback regulation of intraluminal pressure and AP-related CI efflux
(from ASM)in the expanding lung.
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conclusive evidence to back these interventions is awaited. Further
scientific investigations may in time help optimize such prenatal therapies
by providing a better understanding of the determinants of lung growth.
Enthusiasm, dedication and lateral thinking from researchers and surgeons
of the future may provide solutions to the ongoing high mortality and
morbidity seen in CDH.
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